| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.881 | 0.006 | 0.927 | Antiinflammatory | 0.927 0.005 DBMET00153 0.893 0.005 DBMET00154 0.829 0.012 DBMET00155 0.802 0.015 DBMET00668 0.848 0.009 DBMET00808 | DBMET00153 | |
| 0.737 | 0.003 | 0.737 | Anesthetic general | 0.675 0.004 DBMET00153 0.672 0.004 DBMET00154 0.68 0.004 DBMET00155 0.597 0.005 DBMET00668 0.707 0.003 DBMET00808 | ||
| 0.685 | 0.004 | 0.685 | Cyclooxygenase 1 inhibitor | 0.411 0.007 DBMET00153 0.512 0.005 DBMET00154 0.509 0.005 DBMET00155 0.498 0.005 DBMET00668 0.583 0.004 DBMET00808 | ||
| 0.685 | 0.015 | 0.685 | Analgesic | 0.411 0.08 DBMET00153 0.632 0.022 DBMET00154 0.432 0.071 DBMET00155 0.544 0.038 DBMET00668 0.622 0.023 DBMET00808 | ||
| 0.649 | 0.004 | 0.865 | Non-steroidal antiinflammatory agent | 0.865 0.003 DBMET00153 0.479 0.008 DBMET00154 0.511 0.006 DBMET00155 0.426 0.011 DBMET00668 0.555 0.005 DBMET00808 | DBMET00153 | |
| 0.642 | 0.004 | 0.713 | Amyloid beta precursor protein antagonist | 0.19 0.065 DBMET00153 0.575 0.004 DBMET00154 0.713 0.003 DBMET00155 0.517 0.005 DBMET00668 0.6 0.004 DBMET00808 | DBMET00155 | |
| 0.643 | 0.013 | 0.766 | Cholesterol antagonist | 0.766 0.005 DBMET00153 0.596 0.019 DBMET00154 0.64 0.014 DBMET00155 0.615 0.017 DBMET00668 0.611 0.017 DBMET00808 | DBMET00153 | |
| 0.601 | 0.002 | 0.784 | Cyclooxygenase 3 inhibitor | 0.784 0.001 DBMET00153 0.316 0.005 DBMET00154 0.521 0.003 DBMET00155 0.459 0.004 DBMET00668 0.491 0.003 DBMET00808 | DBMET00153 | |
| 0.584 | 0.033 | 0.887 | Transcription factor NF kappa B inhibitor | 0.887 0.007 DBMET00153 0.407 0.062 DBMET00154 0.531 0.04 DBMET00155 0.631 0.028 DBMET00668 0.452 0.052 DBMET00808 | DBMET00153 | |
| 0.544 | 0.022 | 0.625 | Immunosuppressant | 0.625 0.01 DBMET00153 0.567 0.018 DBMET00154 0.552 0.02 DBMET00155 0.468 0.042 DBMET00668 0.473 0.04 DBMET00808 | DBMET00153 | |
| 0.54 | 0.04 | 0.831 | Cyclophilin D inhibitor | 0.766 0.009 DBMET00153 0.831 0.005 DBMET00154 0.551 0.037 DBMET00155 0.645 0.02 DBMET00668 0.675 0.017 DBMET00808 | DBMET00154 | |
| 0.498 | 0.005 | 0.498 | Cyclooxygenase inhibitor | 0.324 0.014 DBMET00153 0.379 0.009 DBMET00154 0.448 0.005 DBMET00155 0.359 0.01 DBMET00668 0.465 0.005 DBMET00808 | ||
| 0.517 | 0.025 | 0.517 | 5 Hydroxytryptamine release stimulant | 0.414 0.043 DBMET00153 0.208 0.114 DBMET00154 0.259 0.085 DBMET00155 0.188 0.132 DBMET00668 0.339 0.059 DBMET00808 | ||
| 0.504 | 0.027 | 0.563 | Histamine release inhibitor | 0.563 0.014 DBMET00153 0.408 0.072 DBMET00154 0.444 0.053 DBMET00155 0.497 0.03 DBMET00668 0.427 0.062 DBMET00808 | DBMET00153 | |
| 0.487 | 0.014 | 0.651 | Hypolipemic | 0.452 0.017 DBMET00153 0.651 0.005 DBMET00154 0.447 0.018 DBMET00155 0.458 0.016 DBMET00668 0.551 0.009 DBMET00808 | DBMET00154 | |
| 0.485 | 0.014 | 0.485 | Superoxide dismutase inhibitor | 0.376 0.031 DBMET00154 0.462 0.017 DBMET00155 0.362 0.034 DBMET00668 0.436 0.021 DBMET00808 | ||
| 0.501 | 0.032 | 0.501 | 5 Hydroxytryptamine release inhibitor | 0.451 0.051 DBMET00153 0.344 0.121 DBMET00154 0.489 0.036 DBMET00155 0.422 0.065 DBMET00668 0.465 0.045 DBMET00808 | ||
| 0.459 | 0.006 | 0.459 | Sodium/bile acid cotransporter inhibitor | 0.436 0.009 DBMET00153 0.432 0.01 DBMET00154 0.432 0.01 DBMET00155 0.442 0.008 DBMET00668 0.436 0.009 DBMET00808 | ||
| 0.461 | 0.019 | 0.623 | Hypoglycemic | 0.623 0.007 DBMET00153 0.512 0.014 DBMET00154 0.444 0.021 DBMET00155 0.364 0.034 DBMET00668 0.421 0.024 DBMET00808 | DBMET00153 | |
| 0.444 | 0.005 | 0.444 | Tyrosine 3 hydroxylase inhibitor | 0.417 0.006 DBMET00154 0.377 0.011 DBMET00155 0.312 0.028 DBMET00668 0.414 0.007 DBMET00808 | ||
| 0.444 | 0.017 | 0.546 | Interleukin 2 agonist | 0.546 0.005 DBMET00153 0.313 0.065 DBMET00154 0.37 0.037 DBMET00155 0.4 0.027 DBMET00668 0.366 0.039 DBMET00808 | DBMET00153 | |
| 0.427 | 0.004 | 0.427 | Gastrin inhibitor | 0.312 0.025 DBMET00153 0.42 0.004 DBMET00154 0.391 0.005 DBMET00155 0.352 0.01 DBMET00668 0.398 0.005 DBMET00808 | ||
| 0.458 | 0.036 | 0.686 | Antithrombotic | 0.686 0.009 DBMET00153 0.367 0.059 DBMET00154 0.4 0.049 DBMET00155 0.492 0.03 DBMET00668 0.542 0.023 DBMET00808 | DBMET00153 | |
| 0.424 | 0.005 | 0.424 | Cell adhesion inhibitor | 0.421 0.005 DBMET00153 0.218 0.02 DBMET00154 0.25 0.015 DBMET00155 0.18 0.031 DBMET00668 0.388 0.005 DBMET00808 | ||
| 0.42 | 0.004 | 0.42 | Interleukin 8 antagonist | 0.11 0.076 DBMET00153 0.231 0.007 DBMET00154 0.25 0.005 DBMET00155 0.147 0.036 DBMET00668 0.262 0.005 DBMET00808 | ||
| 0.438 | 0.026 | 0.438 | Interleukin antagonist | 0.171 0.103 DBMET00153 0.235 0.067 DBMET00154 0.291 0.05 DBMET00155 0.363 0.037 DBMET00668 0.349 0.039 DBMET00808 | ||
| 0.414 | 0.01 | 0.464 | Thrombolytic | 0.394 0.012 DBMET00153 0.273 0.029 DBMET00154 0.375 0.014 DBMET00155 0.286 0.026 DBMET00668 0.464 0.006 DBMET00808 | DBMET00808 | |
| 0.408 | 0.008 | 0.483 | Alpha-N-acetylglucosaminidase inhibitor | 0.483 0.006 DBMET00153 0.366 0.011 DBMET00154 0.429 0.008 DBMET00155 0.412 0.008 DBMET00668 0.366 0.011 DBMET00808 | DBMET00153 | |
| 0.417 | 0.019 | 0.473 | Calcium channel activator | 0.473 0.007 DBMET00154 0.373 0.036 DBMET00155 0.467 0.008 DBMET00668 0.391 0.028 DBMET00808 | DBMET00154 | |
| 0.438 | 0.043 | 0.438 | Calpain 2 inhibitor | 0.303 0.112 DBMET00155 0.34 0.091 DBMET00668 0.311 0.107 DBMET00808 | ||
| 0.432 | 0.046 | 0.439 | Vasodilator, peripheral | 0.435 0.045 DBMET00153 0.237 0.138 DBMET00154 0.317 0.089 DBMET00155 0.439 0.044 DBMET00668 0.285 0.105 DBMET00808 | DBMET00668 | |
| 0.393 | 0.008 | 0.406 | Interleukin 6 antagonist | 0.224 0.03 DBMET00153 0.337 0.011 DBMET00154 0.349 0.01 DBMET00155 0.377 0.009 DBMET00668 0.406 0.007 DBMET00808 | DBMET00808 | |
| 0.363 | 0.007 | 0.363 | Chelator | 0.125 0.049 DBMET00153 0.255 0.016 DBMET00154 0.255 0.016 DBMET00155 0.208 0.023 DBMET00668 0.269 0.014 DBMET00808 | ||
| 0.363 | 0.008 | 0.442 | Insulin secretagoues | 0.339 0.009 DBMET00153 0.319 0.01 DBMET00154 0.404 0.006 DBMET00155 0.255 0.019 DBMET00668 0.442 0.005 DBMET00808 | DBMET00808 | |
| 0.391 | 0.042 | 0.585 | Spasmolytic | 0.585 0.014 DBMET00153 0.314 0.065 DBMET00154 0.331 0.059 DBMET00155 0.578 0.015 DBMET00668 0.323 0.061 DBMET00808 | DBMET00153 | |
| 0.389 | 0.04 | 0.389 | Lipoxygenase inhibitor | 0.237 0.109 DBMET00154 0.337 0.055 DBMET00155 0.266 0.089 DBMET00668 0.308 0.068 DBMET00808 | ||
| 0.351 | 0.009 | 0.351 | Cyclooxygenase 2 inhibitor | 0.219 0.026 DBMET00153 0.258 0.019 DBMET00154 0.328 0.01 DBMET00155 0.22 0.026 DBMET00668 0.328 0.01 DBMET00808 | ||
| 0.362 | 0.026 | 0.499 | Interleukin agonist | 0.499 0.009 DBMET00153 0.333 0.034 DBMET00154 0.292 0.052 DBMET00155 0.364 0.025 DBMET00668 0.285 0.056 DBMET00808 | DBMET00153 | |
| 0.383 | 0.049 | 0.523 | Immunomodulator | 0.523 0.02 DBMET00153 0.429 0.036 DBMET00154 0.488 0.025 DBMET00155 0.293 0.086 DBMET00668 0.242 0.121 DBMET00808 | DBMET00153 | |
| 0.361 | 0.03 | 0.361 | Insulysin inhibitor | 0.223 0.125 DBMET00154 0.296 0.061 DBMET00155 0.202 0.154 DBMET00668 0.322 0.046 DBMET00808 | ||
| 0.332 | 0.004 | 0.352 | Mucolytic | 0.352 0.004 DBMET00153 0.196 0.014 DBMET00154 0.266 0.005 DBMET00155 0.277 0.005 DBMET00668 0.253 0.006 DBMET00808 | DBMET00153 | |
| 0.328 | 0.01 | 0.351 | Phospholipase A2 inhibitor | 0.256 0.022 DBMET00153 0.218 0.034 DBMET00154 0.265 0.02 DBMET00155 0.218 0.034 DBMET00668 0.351 0.008 DBMET00808 | DBMET00808 | |
| 0.323 | 0.007 | 0.64 | Expectorant | 0.64 0.002 DBMET00153 0.173 0.027 DBMET00154 0.254 0.012 DBMET00155 0.276 0.01 DBMET00668 0.237 0.014 DBMET00808 | DBMET00153 | |
| 0.365 | 0.052 | 0.405 | Aldehyde oxidase inhibitor | 0.218 0.096 DBMET00154 0.405 0.046 DBMET00155 0.289 0.069 DBMET00668 0.292 0.068 DBMET00808 | DBMET00155 | |
| 0.318 | 0.008 | 0.318 | GABA C receptor agonist | 0.28 0.011 DBMET00154 0.187 0.023 DBMET00155 0.197 0.021 DBMET00668 0.28 0.011 DBMET00808 | ||
| 0.312 | 0.005 | 0.328 | Cell adhesion molecule inhibitor | 0.278 0.005 DBMET00153 0.156 0.014 DBMET00154 0.179 0.011 DBMET00155 0.117 0.025 DBMET00668 0.328 0.005 DBMET00808 | DBMET00808 | |
| 0.342 | 0.036 | 0.342 | Amyloid beta aggregation inhibitor | 0.197 0.079 DBMET00153 0.131 0.124 DBMET00154 0.188 0.084 DBMET00155 0.226 0.066 DBMET00668 0.202 0.077 DBMET00808 | ||
| 0.351 | 0.046 | 0.691 | Antioxidant | 0.691 0.006 DBMET00153 0.32 0.055 DBMET00154 0.326 0.053 DBMET00155 0.318 0.055 DBMET00668 0.288 0.066 DBMET00808 | DBMET00153 | |
| 0.317 | 0.014 | 0.317 | Neurotrophic factor enhancer | 0.288 0.022 DBMET00153 0.269 0.029 DBMET00154 0.263 0.032 DBMET00155 0.208 0.069 DBMET00668 0.262 0.032 DBMET00808 | ||
| 0.355 | 0.053 | 0.49 | Apoptosis antagonist | 0.49 0.022 DBMET00153 0.215 0.162 DBMET00154 0.298 0.087 DBMET00155 0.365 0.049 DBMET00668 0.32 0.073 DBMET00808 | DBMET00153 | |
| 0.339 | 0.041 | 0.437 | Platelet antagonist | 0.411 0.025 DBMET00153 0.271 0.064 DBMET00154 0.299 0.053 DBMET00155 0.349 0.038 DBMET00668 0.437 0.021 DBMET00808 | DBMET00808 | |
| 0.326 | 0.033 | 0.336 | 5 Hydroxytryptamine uptake stimulant | 0.336 0.03 DBMET00154 0.236 0.095 DBMET00155 0.23 0.103 DBMET00668 0.298 0.046 DBMET00808 | DBMET00154 | |
| 0.301 | 0.01 | 0.322 | Succinate dehydrogenase inhibitor | 0.229 0.031 DBMET00154 0.309 0.009 DBMET00155 0.27 0.017 DBMET00668 0.322 0.008 DBMET00808 | DBMET00808 | |
| 0.296 | 0.008 | 0.333 | Ferrochelatase inhibitor | 0.265 0.011 DBMET00154 0.174 0.029 DBMET00155 0.333 0.005 DBMET00668 0.265 0.011 DBMET00808 | DBMET00668 | |
| 0.344 | 0.058 | 0.527 | Vasodilator, coronary | 0.527 0.012 DBMET00153 0.294 0.092 DBMET00154 0.347 0.057 DBMET00155 0.344 0.058 DBMET00668 0.313 0.077 DBMET00808 | DBMET00153 | |
| 0.327 | 0.044 | 0.582 | Antiamyloidogenic | 0.582 0.009 DBMET00153 0.155 0.141 DBMET00154 0.27 0.063 DBMET00155 0.35 0.039 DBMET00668 0.23 0.081 DBMET00808 | DBMET00153 | |
| 0.34 | 0.057 | 0.34 | Nootropic | 0.214 0.14 DBMET00154 0.211 0.144 DBMET00155 0.323 0.063 DBMET00668 0.266 0.095 DBMET00808 | ||
| 0.278 | 0.005 | 0.278 | Vanilloid 1 agonist | 0.232 0.007 DBMET00153 0.203 0.011 DBMET00154 0.235 0.006 DBMET00155 0.156 0.032 DBMET00668 0.22 0.008 DBMET00808 | ||
| 0.272 | 0.003 | 0.272 | Sphingosine 1-phosphate receptor 5 antagonist | 0.197 0.013 DBMET00154 0.241 0.004 DBMET00155 0.17 0.034 DBMET00668 0.234 0.004 DBMET00808 | ||
| 0.272 | 0.004 | 0.272 | Sphingosine 1-phosphate receptor 2 antagonist | 0.2 0.008 DBMET00154 0.216 0.005 DBMET00155 0.189 0.011 DBMET00668 0.211 0.005 DBMET00808 | ||
| 0.287 | 0.019 | 0.287 | Insulin sensitizer | 0.219 0.056 DBMET00153 0.252 0.033 DBMET00154 0.254 0.032 DBMET00155 0.246 0.036 DBMET00668 0.278 0.022 DBMET00808 | ||
| 0.268 | 0.01 | 0.297 | ATPase inhibitor | 0.297 0.006 DBMET00153 0.222 0.023 DBMET00154 0.216 0.026 DBMET00155 0.235 0.018 DBMET00668 0.22 0.024 DBMET00808 | DBMET00153 | |
| 0.253 | 0.004 | 0.253 | Bile acid receptor antagonist | 0.117 0.023 DBMET00153 0.135 0.011 DBMET00154 0.186 0.005 DBMET00155 0.156 0.006 DBMET00668 0.191 0.005 DBMET00808 | ||
| 0.286 | 0.037 | 0.286 | Calpain inhibitor | 0.176 0.139 DBMET00153 0.226 0.088 DBMET00155 0.218 0.097 DBMET00668 0.238 0.076 DBMET00808 | ||
| 0.252 | 0.005 | 0.255 | Arachidonic acid antagonist | 0.193 0.04 DBMET00153 0.247 0.006 DBMET00154 0.255 0.005 DBMET00155 0.24 0.008 DBMET00668 0.246 0.006 DBMET00808 | DBMET00155 | |
| 0.261 | 0.016 | 0.289 | Cholesterol synthesis inhibitor | 0.177 0.033 DBMET00153 0.271 0.015 DBMET00154 0.252 0.017 DBMET00155 0.289 0.013 DBMET00668 0.233 0.02 DBMET00808 | DBMET00668 | |
| 0.264 | 0.022 | 0.264 | Phospholipase C inhibitor | 0.201 0.043 DBMET00153 0.222 0.033 DBMET00154 0.225 0.031 DBMET00155 0.186 0.054 DBMET00668 0.205 0.04 DBMET00808 | ||
| 0.254 | 0.012 | 0.269 | Aminopeptidase B inhibitor | 0.166 0.031 DBMET00154 0.24 0.014 DBMET00155 0.169 0.03 DBMET00668 0.269 0.011 DBMET00808 | DBMET00808 | |
| 0.244 | 0.004 | 0.244 | Prolactin inhibitor | 0.173 0.014 DBMET00154 0.171 0.015 DBMET00155 0.143 0.025 DBMET00668 0.191 0.01 DBMET00808 | ||
| 0.278 | 0.042 | 0.409 | Peroxidase inhibitor | 0.16 0.073 DBMET00154 0.23 0.052 DBMET00155 0.409 0.019 DBMET00668 0.221 0.054 DBMET00808 | DBMET00668 | |
| 0.273 | 0.043 | 0.389 | Platelet aggregation inhibitor | 0.23 0.062 DBMET00154 0.28 0.041 DBMET00155 0.389 0.02 DBMET00668 0.295 0.037 DBMET00808 | DBMET00668 | |
| 0.337 | 0.109 | 0.658 | Antibacterial | 0.658 0.012 DBMET00153 0.234 0.192 DBMET00154 0.303 0.133 DBMET00155 0.504 0.039 DBMET00668 0.323 0.119 DBMET00808 | DBMET00153 | |
| 0.283 | 0.056 | 0.582 | Free radical scavenger | 0.582 0.01 DBMET00153 0.193 0.104 DBMET00154 0.251 0.068 DBMET00155 0.191 0.105 DBMET00668 0.206 0.093 DBMET00808 | DBMET00153 | |
| 0.227 | 0.007 | 0.242 | HIV-1 integrase (Overall Integration) inhibitor | 0.186 0.015 DBMET00154 0.194 0.013 DBMET00155 0.242 0.005 DBMET00668 0.207 0.01 DBMET00808 | DBMET00668 | |
| 0.224 | 0.005 | 0.356 | Peroxisome proliferator-activated receptor gamma agonist | 0.069 0.05 DBMET00153 0.315 0.004 DBMET00154 0.16 0.011 DBMET00155 0.131 0.017 DBMET00668 0.356 0.004 DBMET00808 | DBMET00808 | |
| 0.223 | 0.007 | 0.227 | ABCA1 expression enhancer | 0.225 0.007 DBMET00154 0.227 0.007 DBMET00155 0.163 0.014 DBMET00668 0.18 0.012 DBMET00808 | DBMET00155 | |
| 0.216 | 0.003 | 0.216 | CXC chemokine 1 receptor antagonist | 0.119 0.005 DBMET00154 0.151 0.004 DBMET00155 0.141 0.004 DBMET00668 0.182 0.004 DBMET00808 | ||
| 0.293 | 0.08 | 0.558 | Immunostimulant | 0.558 0.022 DBMET00153 0.273 0.087 DBMET00154 0.244 0.099 DBMET00155 0.248 0.097 DBMET00668 0.251 0.096 DBMET00808 | DBMET00153 | |
| 0.217 | 0.006 | 0.233 | Aminopeptidase I inhibitor | 0.072 0.051 DBMET00153 0.129 0.017 DBMET00154 0.211 0.006 DBMET00155 0.139 0.015 DBMET00668 0.233 0.005 DBMET00808 | DBMET00808 | |
| 0.231 | 0.023 | 0.231 | Interleukin 1 antagonist | 0.148 0.059 DBMET00154 0.137 0.068 DBMET00155 0.139 0.066 DBMET00668 0.195 0.035 DBMET00808 | ||
| 0.212 | 0.006 | 0.212 | Vanilloid agonist | 0.115 0.021 DBMET00153 0.114 0.022 DBMET00154 0.155 0.01 DBMET00155 0.105 0.029 DBMET00668 0.158 0.01 DBMET00808 | ||
| 0.236 | 0.03 | 0.287 | Protein kinase stimulant | 0.287 0.019 DBMET00153 0.18 0.05 DBMET00154 0.22 0.035 DBMET00155 0.264 0.023 DBMET00668 0.257 0.025 DBMET00808 | DBMET00153 | |
| 0.206 | 0.003 | 0.206 | Glutamate (mGluR3) antagonist | 0.051 0.012 DBMET00154 0.083 0.005 DBMET00155 0.043 0.018 DBMET00668 0.204 0.003 DBMET00808 | ||
| 0.251 | 0.051 | 0.507 | Nitric oxide antagonist | 0.507 0.015 DBMET00153 0.289 0.043 DBMET00154 0.202 0.066 DBMET00155 0.226 0.059 DBMET00668 0.227 0.058 DBMET00808 | DBMET00153 | |
| 0.201 | 0.007 | 0.201 | Prostaglandin antagonist | 0.067 0.028 DBMET00154 0.084 0.022 DBMET00155 0.106 0.016 DBMET00668 0.198 0.007 DBMET00808 | ||
| 0.209 | 0.015 | 0.209 | Cathepsin G inhibitor | 0.078 0.045 DBMET00154 0.107 0.031 DBMET00155 0.113 0.029 DBMET00668 0.134 0.024 DBMET00808 | ||
| 0.22 | 0.027 | 0.22 | Neurotensin receptor agonist | 0.166 0.069 DBMET00154 0.185 0.045 DBMET00155 0.162 0.075 DBMET00668 0.204 0.033 DBMET00808 | ||
| 0.203 | 0.01 | 0.282 | Triose-phosphate isomerase inhibitor | 0.282 0.005 DBMET00153 0.269 0.006 DBMET00154 0.222 0.009 DBMET00155 0.217 0.009 DBMET00668 0.179 0.014 DBMET00808 | DBMET00153 | |
| 0.225 | 0.033 | 0.339 | Melanin inhibitor | 0.339 0.017 DBMET00153 0.205 0.039 DBMET00154 0.203 0.039 DBMET00155 0.209 0.037 DBMET00668 0.202 0.04 DBMET00808 | DBMET00153 | |
| 0.229 | 0.041 | 0.263 | Lipocortins synthesis antagonist | 0.167 0.084 DBMET00153 0.263 0.029 DBMET00154 0.209 0.051 DBMET00155 0.197 0.058 DBMET00668 0.214 0.048 DBMET00808 | DBMET00154 | |
| 0.192 | 0.004 | 0.248 | Peroxisome proliferator-activated receptor alpha agonist | 0.176 0.005 DBMET00154 0.141 0.007 DBMET00155 0.1 0.012 DBMET00668 0.248 0.004 DBMET00808 | DBMET00808 | |
| 0.195 | 0.008 | 0.202 | Integrin antagonist | 0.053 0.026 DBMET00154 0.062 0.024 DBMET00155 0.202 0.007 DBMET00808 | DBMET00808 | |
| 0.252 | 0.069 | 0.714 | Angiogenesis stimulant | 0.714 0.004 DBMET00153 0.22 0.084 DBMET00154 0.267 0.062 DBMET00155 0.159 0.117 DBMET00668 0.226 0.081 DBMET00808 | DBMET00153 | |
| 0.196 | 0.014 | 0.196 | GABA C receptor antagonist | 0.193 0.014 DBMET00154 0.148 0.031 DBMET00155 0.151 0.029 DBMET00668 0.175 0.019 DBMET00808 | ||
| 0.196 | 0.016 | 0.196 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.182 0.019 DBMET00153 0.169 0.022 DBMET00154 0.15 0.027 DBMET00155 0.132 0.033 DBMET00668 0.169 0.022 DBMET00808 | ||
| 0.195 | 0.016 | 0.245 | Catalase inhibitor | 0.153 0.025 DBMET00154 0.202 0.015 DBMET00155 0.245 0.009 DBMET00668 0.175 0.02 DBMET00808 | DBMET00668 | |
| 0.217 | 0.039 | 0.217 | Antipruritic | 0.183 0.062 DBMET00155 0.134 0.115 DBMET00668 0.133 0.117 DBMET00808 | ||
| 0.335 | 0.158 | 0.496 | Caspase 9 stimulant | 0.496 0.061 DBMET00153 0.44 0.088 DBMET00154 0.31 0.183 DBMET00155 0.313 0.18 DBMET00668 0.297 0.197 DBMET00808 | DBMET00153 | |
| 0.215 | 0.039 | 0.411 | Amylase inhibitor | 0.411 0.009 DBMET00153 0.151 0.063 DBMET00154 0.257 0.026 DBMET00155 0.18 0.051 DBMET00668 0.153 0.063 DBMET00808 | DBMET00153 | |
| 0.186 | 0.014 | 0.186 | TRPA1 agonist | 0.1 0.088 DBMET00153 0.179 0.016 DBMET00154 0.145 0.035 DBMET00155 0.15 0.031 DBMET00668 0.168 0.02 DBMET00808 | ||
| 0.194 | 0.023 | 0.194 | Antibacterial (Helicobacter pylori) | 0.178 0.029 DBMET00153 0.135 0.061 DBMET00155 0.147 0.048 DBMET00668 0.126 0.072 DBMET00808 | ||
| 0.172 | 0.005 | 0.215 | Peroxisome proliferator-activated receptor gamma antagonist | 0.173 0.005 DBMET00154 0.161 0.005 DBMET00155 0.12 0.01 DBMET00668 0.215 0.004 DBMET00808 | DBMET00808 | |
| 0.194 | 0.027 | 0.194 | Proteasome inhibitor | 0.141 0.052 DBMET00154 0.184 0.03 DBMET00155 0.168 0.037 DBMET00668 0.16 0.041 DBMET00808 | ||
| 0.2 | 0.033 | 0.518 | Monophenol monooxygenase inhibitor | 0.518 0.007 DBMET00153 0.131 0.055 DBMET00154 0.146 0.048 DBMET00155 0.133 0.054 DBMET00668 0.146 0.049 DBMET00808 | DBMET00153 | |
| 0.174 | 0.009 | 0.196 | Argininosuccinate synthase inhibitor | 0.072 0.029 DBMET00153 0.184 0.009 DBMET00154 0.112 0.017 DBMET00155 0.138 0.013 DBMET00668 0.196 0.008 DBMET00808 | DBMET00808 | |
| 0.168 | 0.003 | 0.203 | Estrogen-related receptor beta agonist | 0.084 0.055 DBMET00153 0.125 0.008 DBMET00154 0.203 0.003 DBMET00155 0.125 0.008 DBMET00668 0.157 0.004 DBMET00808 | DBMET00155 | |
| 0.196 | 0.032 | 0.379 | Cell wall synthesis inhibitor | 0.379 0.007 DBMET00153 0.154 0.062 DBMET00154 0.179 0.04 DBMET00155 0.342 0.008 DBMET00668 0.189 0.035 DBMET00808 | DBMET00153 | |
| 0.169 | 0.007 | 0.169 | Ornithine decarboxylase inhibitor | 0.108 0.036 DBMET00153 0.124 0.023 DBMET00154 0.15 0.011 DBMET00155 0.149 0.011 DBMET00668 0.148 0.012 DBMET00808 | ||
| 0.163 | 0.004 | 0.18 | GABA B receptor agonist | 0.18 0.004 DBMET00154 0.142 0.005 DBMET00155 0.172 0.004 DBMET00668 0.144 0.005 DBMET00808 | DBMET00154 | |
| 0.215 | 0.057 | 0.451 | Hepatoprotectant | 0.451 0.01 DBMET00153 0.183 0.078 DBMET00154 0.174 0.085 DBMET00155 0.192 0.07 DBMET00668 0.197 0.066 DBMET00808 | DBMET00153 | |
| 0.186 | 0.028 | 0.186 | 5-Lipoxygenase inhibitor | 0.1 0.064 DBMET00155 0.116 0.052 DBMET00668 0.142 0.041 DBMET00808 | ||
| 0.17 | 0.013 | 0.17 | DOPA decarboxylase inhibitor | 0.138 0.029 DBMET00154 0.149 0.022 DBMET00155 0.115 0.051 DBMET00668 0.158 0.017 DBMET00808 | ||
| 0.172 | 0.018 | 0.172 | Sphingosine 1-phosphate receptor 4 antagonist | 0.108 0.098 DBMET00154 0.139 0.045 DBMET00155 0.131 0.054 DBMET00808 | ||
| 0.162 | 0.009 | 0.179 | Leukotriene antagonist | 0.103 0.02 DBMET00153 0.157 0.009 DBMET00154 0.13 0.013 DBMET00155 0.179 0.007 DBMET00668 0.165 0.008 DBMET00808 | DBMET00668 | |
| 0.176 | 0.025 | 0.176 | Nav1.4 sodium channel blocker | 0.101 0.074 DBMET00155 0.146 0.035 DBMET00668 0.109 0.064 DBMET00808 | ||
| 0.166 | 0.017 | 0.166 | Porphobilinogen synthase inhibitor | 0.139 0.023 DBMET00154 0.088 0.042 DBMET00155 0.097 0.037 DBMET00668 0.139 0.023 DBMET00808 | ||
| 0.182 | 0.034 | 0.192 | DNA polymerase I inhibitor | 0.192 0.031 DBMET00153 0.164 0.042 DBMET00154 0.168 0.04 DBMET00155 0.156 0.046 DBMET00668 0.167 0.041 DBMET00808 | DBMET00153 | |
| 0.151 | 0.003 | 0.151 | AICAR transformylase inhibitor | 0.052 0.02 DBMET00153 0.107 0.004 DBMET00154 0.086 0.006 DBMET00155 0.072 0.009 DBMET00668 0.116 0.004 DBMET00808 | ||
| 0.152 | 0.007 | 0.17 | GABA aminotransferase inhibitor | 0.145 0.009 DBMET00153 0.149 0.008 DBMET00154 0.12 0.016 DBMET00155 0.097 0.029 DBMET00668 0.17 0.005 DBMET00808 | DBMET00808 | |
| 0.149 | 0.007 | 0.149 | 5-Alpha-reductase inhibitor | 0.038 0.025 DBMET00154 0.091 0.011 DBMET00155 0.071 0.014 DBMET00668 0.092 0.011 DBMET00808 | ||
| 0.177 | 0.035 | 0.191 | Toll-Like receptor 2 antagonist | 0.178 0.035 DBMET00155 0.102 0.101 DBMET00668 0.191 0.028 DBMET00808 | DBMET00808 | |
| 0.164 | 0.023 | 0.314 | Mediator release inhibitor | 0.314 0.007 DBMET00153 0.118 0.05 DBMET00154 0.14 0.034 DBMET00155 0.145 0.031 DBMET00668 0.124 0.044 DBMET00808 | DBMET00153 | |
| 0.156 | 0.015 | 0.174 | Glutamate dehydrogenase inhibitor | 0.078 0.047 DBMET00153 0.148 0.016 DBMET00154 0.114 0.025 DBMET00155 0.138 0.018 DBMET00668 0.174 0.012 DBMET00808 | DBMET00808 | |
| 0.214 | 0.073 | 0.214 | Anticonvulsant | 0.158 0.12 DBMET00154 0.144 0.137 DBMET00668 0.195 0.087 DBMET00808 | ||
| 0.259 | 0.118 | 0.33 | Thyroid hormone antagonist | 0.222 0.143 DBMET00155 0.33 0.081 DBMET00808 | DBMET00808 | |
| 0.172 | 0.033 | 0.193 | Adenylate cyclase stimulant | 0.132 0.098 DBMET00153 0.162 0.045 DBMET00154 0.163 0.044 DBMET00155 0.193 0.017 DBMET00668 0.163 0.043 DBMET00808 | DBMET00668 | |
| 0.146 | 0.007 | 0.146 | Sphingosine 1-phosphate receptor antagonist | 0.078 0.049 DBMET00154 0.097 0.024 DBMET00155 0.104 0.019 DBMET00668 0.105 0.019 DBMET00808 | ||
| 0.156 | 0.017 | 0.23 | Phosphofructokinase-1 inhibitor | 0.23 0.009 DBMET00153 0.174 0.014 DBMET00154 0.164 0.016 DBMET00155 0.131 0.022 DBMET00668 0.172 0.014 DBMET00808 | DBMET00153 | |
| 0.142 | 0.004 | 0.18 | Peroxisome proliferator-activated receptor alpha antagonist | 0.145 0.004 DBMET00154 0.088 0.005 DBMET00155 0.057 0.007 DBMET00668 0.18 0.003 DBMET00808 | DBMET00808 | |
| 0.187 | 0.049 | 0.211 | Diuretic | 0.211 0.04 DBMET00153 0.18 0.053 DBMET00155 0.179 0.054 DBMET00808 | DBMET00153 | |
| 0.16 | 0.024 | 0.169 | Ca2+-transporting ATPase inhibitor | 0.169 0.013 DBMET00153 0.163 0.019 DBMET00154 0.157 0.028 DBMET00155 0.166 0.017 DBMET00668 0.155 0.032 DBMET00808 | DBMET00153 | |
| 0.139 | 0.004 | 0.161 | AMPA 4 receptor antagonist | 0.094 0.005 DBMET00154 0.071 0.008 DBMET00155 0.067 0.008 DBMET00668 0.161 0.004 DBMET00808 | DBMET00808 | |
| 0.183 | 0.049 | 0.317 | Interferon gamma antagonist | 0.317 0.018 DBMET00153 0.254 0.028 DBMET00154 0.165 0.061 DBMET00155 0.169 0.058 DBMET00668 0.168 0.059 DBMET00808 | DBMET00153 | |
| 0.14 | 0.007 | 0.14 | Ca(v)3.1 blocker | |||
| 0.14 | 0.008 | 0.17 | Glycine receptor agonist | 0.117 0.014 DBMET00153 0.17 0.005 DBMET00154 0.134 0.009 DBMET00155 0.121 0.012 DBMET00668 0.124 0.011 DBMET00808 | DBMET00154 | |
| 0.167 | 0.037 | 0.278 | Farnesoid X receptor antagonist | 0.278 0.008 DBMET00154 0.144 0.059 DBMET00155 0.135 0.073 DBMET00668 0.139 0.068 DBMET00808 | DBMET00154 | |
| 0.243 | 0.113 | 0.243 | 12-Lipoxygenase inhibitor | 0.188 0.165 DBMET00808 | ||
| 0.154 | 0.025 | 0.154 | Caspase 3 inhibitor | 0.104 0.085 DBMET00154 0.134 0.042 DBMET00155 0.128 0.049 DBMET00668 0.134 0.042 DBMET00808 | ||
| 0.207 | 0.078 | 0.229 | Nitric-oxide synthase stimulant | 0.194 0.1 DBMET00153 0.176 0.139 DBMET00154 0.183 0.122 DBMET00155 0.229 0.05 DBMET00668 0.193 0.101 DBMET00808 | DBMET00668 | |
| 0.292 | 0.164 | 0.524 | Calcium channel L-type activator | 0.257 0.197 DBMET00154 0.257 0.197 DBMET00155 0.524 0.02 DBMET00668 0.257 0.197 DBMET00808 | DBMET00668 | |
| 0.186 | 0.058 | 0.266 | Anticoagulant | 0.266 0.035 DBMET00153 0.147 0.083 DBMET00155 0.253 0.038 DBMET00808 | DBMET00153 | |
| 0.133 | 0.005 | 0.151 | Aconitate hydratase inhibitor | 0.139 0.005 DBMET00154 0.097 0.009 DBMET00155 0.117 0.006 DBMET00668 0.151 0.004 DBMET00808 | DBMET00808 | |
| 0.221 | 0.093 | 0.345 | DNA synthesis inhibitor | 0.345 0.031 DBMET00153 0.208 0.111 DBMET00154 0.193 0.134 DBMET00155 0.207 0.112 DBMET00668 0.18 0.154 DBMET00808 | DBMET00153 | |
| 0.132 | 0.006 | 0.294 | Macrophage elastase inhibitor | 0.054 0.022 DBMET00154 0.081 0.012 DBMET00155 0.294 0.004 DBMET00668 0.204 0.005 DBMET00808 | DBMET00668 | |
| 0.145 | 0.019 | 0.145 | Interleukin 1 beta converting enzyme inhibitor | 0.113 0.042 DBMET00155 0.101 0.056 DBMET00668 0.12 0.035 DBMET00808 | ||
| 0.127 | 0.004 | 0.127 | Retinoid X alpha receptor agonist | 0.093 0.005 DBMET00154 0.103 0.005 DBMET00155 0.078 0.008 DBMET00668 0.115 0.004 DBMET00808 | ||
| 0.143 | 0.021 | 0.143 | Metalloproteinase-2 inhibitor | 0.121 0.029 DBMET00155 0.135 0.023 DBMET00808 | ||
| 0.125 | 0.005 | 0.142 | Integrin alpha4 antagonist | 0.034 0.015 DBMET00154 0.037 0.014 DBMET00155 0.142 0.005 DBMET00808 | DBMET00808 | |
| 0.121 | 0.004 | 0.121 | DNA helicase inhibitor | 0.058 0.031 DBMET00153 0.115 0.004 DBMET00154 0.1 0.005 DBMET00155 0.103 0.005 DBMET00668 0.115 0.004 DBMET00808 | ||
| 0.144 | 0.029 | 0.154 | Adenylate kinase inhibitor | 0.093 0.08 DBMET00153 0.131 0.036 DBMET00154 0.122 0.042 DBMET00155 0.154 0.025 DBMET00668 0.131 0.036 DBMET00808 | DBMET00668 | |
| 0.147 | 0.033 | 0.164 | Photosensitizer | 0.164 0.024 DBMET00153 0.132 0.044 DBMET00154 0.134 0.042 DBMET00155 0.141 0.037 DBMET00668 0.133 0.044 DBMET00808 | DBMET00153 | |
| 0.135 | 0.022 | 0.135 | Thioredoxin inhibitor | 0.131 0.025 DBMET00153 0.086 0.069 DBMET00154 0.096 0.053 DBMET00155 0.107 0.041 DBMET00808 | ||
| 0.149 | 0.038 | 0.228 | Microtubule formation inhibitor | 0.228 0.014 DBMET00153 0.14 0.044 DBMET00154 0.132 0.05 DBMET00155 0.137 0.045 DBMET00668 0.125 0.055 DBMET00808 | DBMET00153 | |
| 0.132 | 0.02 | 0.14 | Lanosterol 14 alpha demethylase inhibitor | 0.14 0.015 DBMET00154 0.11 0.042 DBMET00155 0.139 0.016 DBMET00668 0.12 0.03 DBMET00808 | DBMET00154 | |
| 0.122 | 0.011 | 0.134 | Prostaglandin E2 antagonist | 0.134 0.01 DBMET00808 | DBMET00808 | |
| 0.112 | 0.005 | 0.158 | Peroxisome proliferator-activated receptor delta agonist | 0.112 0.005 DBMET00154 0.085 0.007 DBMET00155 0.032 0.025 DBMET00668 0.158 0.004 DBMET00808 | DBMET00808 | |
| 0.111 | 0.004 | 0.111 | Nicotinic acid receptor agonist | 0.042 0.019 DBMET00154 0.086 0.005 DBMET00155 0.07 0.009 DBMET00808 | ||
| 0.166 | 0.061 | 0.192 | Hexokinase inhibitor | 0.192 0.04 DBMET00153 0.153 0.076 DBMET00154 0.124 0.112 DBMET00808 | DBMET00153 | |
| 0.124 | 0.019 | 0.151 | Glutamate decarboxylase inhibitor | 0.11 0.024 DBMET00154 0.108 0.026 DBMET00155 0.151 0.013 DBMET00668 0.11 0.024 DBMET00808 | DBMET00668 | |
| 0.118 | 0.014 | 0.118 | Biliverdin reductase inhibitor | 0.102 0.018 DBMET00154 0.084 0.024 DBMET00155 0.098 0.019 DBMET00668 0.102 0.018 DBMET00808 | ||
| 0.133 | 0.029 | 0.133 | Calcium antagonist | 0.099 0.049 DBMET00155 0.09 0.055 DBMET00668 0.089 0.056 DBMET00808 | ||
| 0.107 | 0.004 | 0.109 | Retinoid X receptor agonist | 0.109 0.004 DBMET00154 0.089 0.006 DBMET00155 0.08 0.008 DBMET00668 0.098 0.005 DBMET00808 | DBMET00154 | |
| 0.138 | 0.036 | 0.166 | Protease inhibitor | 0.102 0.064 DBMET00153 0.166 0.023 DBMET00154 0.125 0.044 DBMET00155 0.084 0.081 DBMET00668 0.134 0.038 DBMET00808 | DBMET00154 | |
| 0.145 | 0.043 | 0.145 | Cystathionine beta-synthase inhibitor | 0.126 0.053 DBMET00154 0.105 0.071 DBMET00155 0.1 0.077 DBMET00668 0.126 0.053 DBMET00808 | ||
| 0.107 | 0.006 | 0.107 | Diacylglycerol O-acyltransferase inhibitor | 0.097 0.008 DBMET00154 0.077 0.016 DBMET00155 0.063 0.024 DBMET00668 0.091 0.01 DBMET00808 | ||
| 0.149 | 0.047 | 0.149 | Cathepsin H inhibitor | 0.114 0.083 DBMET00155 0.134 0.059 DBMET00808 | ||
| 0.173 | 0.071 | 0.173 | Growth hormone agonist | 0.146 0.09 DBMET00154 0.163 0.077 DBMET00155 0.154 0.084 DBMET00808 | ||
| 0.108 | 0.008 | 0.116 | Glutamate (mGluR6) antagonist | 0.101 0.01 DBMET00154 0.095 0.013 DBMET00155 0.104 0.009 DBMET00668 0.116 0.006 DBMET00808 | DBMET00808 | |
| 0.121 | 0.022 | 0.132 | Glutamate release inhibitor | 0.132 0.015 DBMET00153 0.087 0.07 DBMET00155 0.114 0.026 DBMET00668 0.096 0.049 DBMET00808 | DBMET00153 | |
| 0.146 | 0.048 | 0.285 | Alkylator | 0.285 0.014 DBMET00153 0.108 0.08 DBMET00154 0.15 0.046 DBMET00155 0.131 0.058 DBMET00668 0.101 0.088 DBMET00808 | DBMET00153 | |
| 0.154 | 0.056 | 0.157 | Bone formation stimulant | 0.143 0.065 DBMET00153 0.157 0.054 DBMET00155 0.146 0.062 DBMET00808 | DBMET00155 | |
| 0.118 | 0.021 | 0.132 | Purinergic P2X2 antagonist | 0.132 0.016 DBMET00155 0.073 0.044 DBMET00668 0.08 0.04 DBMET00808 | DBMET00155 | |
| 0.102 | 0.005 | 0.102 | Glutamate (mGluR4) antagonist | 0.049 0.022 DBMET00154 0.058 0.015 DBMET00155 0.043 0.032 DBMET00668 0.091 0.006 DBMET00808 | ||
| 0.117 | 0.02 | 0.117 | Matrix metalloproteinase inhibitor | 0.099 0.027 DBMET00155 0.066 0.047 DBMET00668 0.107 0.024 DBMET00808 | ||
| 0.145 | 0.048 | 0.145 | Adenylate cyclase inhibitor | 0.12 0.067 DBMET00155 0.137 0.054 DBMET00668 0.113 0.073 DBMET00808 | ||
| 0.111 | 0.016 | 0.119 | Alcohol oxidase inhibitor | 0.09 0.021 DBMET00154 0.119 0.014 DBMET00155 0.098 0.018 DBMET00668 0.09 0.021 DBMET00808 | DBMET00155 | |
| 0.115 | 0.02 | 0.168 | Phenylalanine 4-hydroxylase inhibitor | 0.157 0.011 DBMET00154 0.121 0.018 DBMET00155 0.168 0.009 DBMET00668 0.099 0.026 DBMET00808 | DBMET00668 | |
| 0.103 | 0.008 | 0.103 | Sphingosine 1-phosphate receptor 3 antagonist | 0.053 0.05 DBMET00154 0.08 0.017 DBMET00155 0.064 0.033 DBMET00668 0.075 0.021 DBMET00808 | ||
| 0.1 | 0.005 | 0.164 | Liver X receptor alpha agonist | 0.164 0.004 DBMET00154 0.069 0.009 DBMET00155 0.065 0.01 DBMET00668 0.076 0.007 DBMET00808 | DBMET00154 | |
| 0.178 | 0.083 | 0.481 | Platelet adhesion inhibitor | 0.481 0.006 DBMET00153 0.23 0.057 DBMET00155 0.223 0.06 DBMET00668 | DBMET00153 | |
| 0.157 | 0.063 | 0.157 | Thiol protease inhibitor | 0.15 0.068 DBMET00155 0.122 0.113 DBMET00808 | ||
| 0.28 | 0.187 | 0.693 | Apoptosis agonist | 0.693 0.032 DBMET00153 0.308 0.166 DBMET00155 | DBMET00153 | |
| 0.096 | 0.004 | 0.096 | Glucagon receptor antagonist | 0.036 0.016 DBMET00155 0.058 0.008 DBMET00668 0.06 0.008 DBMET00808 | ||
| 0.125 | 0.035 | 0.164 | Folate antagonist | 0.093 0.078 DBMET00153 0.164 0.018 DBMET00154 0.11 0.049 DBMET00155 0.092 0.082 DBMET00668 0.115 0.043 DBMET00808 | DBMET00154 | |
| 0.101 | 0.011 | 0.101 | Thromboxane antagonist | 0.057 0.035 DBMET00154 0.077 0.022 DBMET00155 0.096 0.013 DBMET00668 0.088 0.016 DBMET00808 | ||
| 0.098 | 0.01 | 0.108 | Nitric oxide donor | 0.108 0.005 DBMET00153 0.076 0.026 DBMET00154 0.088 0.015 DBMET00155 0.079 0.023 DBMET00668 0.085 0.018 DBMET00808 | DBMET00153 | |
| 0.138 | 0.051 | 0.139 | Protein-tyrosine phosphatase 1B inhibitor | 0.139 0.05 DBMET00153 0.125 0.059 DBMET00154 0.106 0.073 DBMET00155 0.134 0.053 DBMET00808 | DBMET00153 | |
| 0.095 | 0.008 | 0.095 | Epithelial sodium channel blocker | 0.055 0.036 DBMET00154 0.073 0.016 DBMET00155 0.067 0.02 DBMET00808 | ||
| 0.106 | 0.02 | 0.107 | Neutrophil collagenase inhibitor | 0.077 0.034 DBMET00154 0.083 0.03 DBMET00155 0.107 0.02 DBMET00808 | DBMET00808 | |
| 0.091 | 0.005 | 0.091 | Cholesterol esterase inhibitor | 0.054 0.024 DBMET00153 0.061 0.017 DBMET00154 0.059 0.019 DBMET00155 0.065 0.013 DBMET00668 0.065 0.013 DBMET00808 | ||
| 0.11 | 0.025 | 0.118 | Keratolytic | 0.114 0.024 DBMET00154 0.118 0.022 DBMET00155 0.09 0.037 DBMET00668 0.096 0.033 DBMET00808 | DBMET00155 | |
| 0.088 | 0.004 | 0.123 | Free fatty acid receptor 1 antagonist | 0.054 0.007 DBMET00154 0.07 0.004 DBMET00155 0.041 0.015 DBMET00668 0.123 0.003 DBMET00808 | DBMET00808 | |
| 0.144 | 0.06 | 0.144 | Nav1.2 sodium channel blocker | |||
| 0.124 | 0.041 | 0.124 | Urease inhibitor | 0.114 0.051 DBMET00668 0.089 0.079 DBMET00808 | ||
| 0.095 | 0.014 | 0.095 | Glutamate (mGluR7) antagonist | 0.062 0.059 DBMET00154 0.067 0.049 DBMET00668 0.089 0.018 DBMET00808 | ||
| 0.096 | 0.015 | 0.096 | Matrix metalloproteinase (membrane-type) inhibitor | 0.077 0.021 DBMET00155 0.087 0.018 DBMET00808 | ||
| 0.089 | 0.009 | 0.127 | Thromboxane synthase inhibitor | 0.079 0.012 DBMET00154 0.089 0.009 DBMET00155 0.061 0.027 DBMET00668 0.127 0.004 DBMET00808 | DBMET00808 | |
| 0.154 | 0.074 | 0.154 | Protein-tyrosine phosphatase inhibitor | 0.141 0.089 DBMET00153 0.135 0.096 DBMET00154 0.122 0.111 DBMET00155 0.15 0.078 DBMET00808 | ||
| 0.084 | 0.004 | 0.1 | Lysine carboxypeptidase inhibitor | 0.048 0.008 DBMET00154 0.074 0.005 DBMET00155 0.048 0.008 DBMET00668 0.1 0.004 DBMET00808 | DBMET00808 | |
| 0.09 | 0.01 | 0.09 | Ca(v)3.2 blocker | |||
| 0.085 | 0.007 | 0.085 | Glutamate (mGluR group III) antagonist | 0.052 0.019 DBMET00154 0.05 0.021 DBMET00155 0.046 0.026 DBMET00668 0.079 0.008 DBMET00808 | ||
| 0.213 | 0.136 | 0.213 | Hypoxia-inducible factor 1 alpha inhibitor | 0.211 0.139 DBMET00668 | ||
| 0.143 | 0.067 | 0.162 | Pregnane X receptor agonist | 0.145 0.063 DBMET00154 0.125 0.114 DBMET00155 0.162 0.034 DBMET00668 0.133 0.092 DBMET00808 | DBMET00668 | |
| 0.1 | 0.024 | 0.1 | Amidase inhibitor | |||
| 0.094 | 0.019 | 0.128 | Aminopeptidase microsomal inhibitor | 0.07 0.031 DBMET00155 0.128 0.012 DBMET00808 | DBMET00808 | |
| 0.113 | 0.04 | 0.113 | Alcohol dehydrogenase inhibitor | 0.088 0.067 DBMET00154 0.104 0.048 DBMET00155 0.098 0.055 DBMET00808 | ||
| 0.078 | 0.006 | 0.102 | Endothelin receptor antagonist | 0.026 0.021 DBMET00154 0.102 0.005 DBMET00155 0.059 0.009 DBMET00668 0.09 0.005 DBMET00808 | DBMET00155 | |
| 0.078 | 0.007 | 0.078 | Immunoglobulin Fc receptor antagonist | 0.067 0.014 DBMET00155 0.072 0.009 DBMET00808 | ||
| 0.175 | 0.106 | 0.175 | Histone acetyltransferase inhibitor | |||
| 0.106 | 0.038 | 0.212 | NADH dehydrogenase inhibitor | 0.212 0.01 DBMET00153 0.097 0.047 DBMET00154 0.1 0.044 DBMET00155 0.109 0.036 DBMET00668 0.097 0.047 DBMET00808 | DBMET00153 | |
| 0.073 | 0.004 | 0.079 | Kainate receptor agonist | 0.056 0.009 DBMET00154 0.053 0.011 DBMET00155 0.058 0.008 DBMET00668 0.079 0.004 DBMET00808 | DBMET00808 | |
| 0.1 | 0.032 | 0.1 | Metalloproteinase-9 inhibitor | 0.08 0.044 DBMET00155 0.069 0.057 DBMET00668 0.091 0.037 DBMET00808 | ||
| 0.076 | 0.009 | 0.115 | Squalene synthetase inhibitor | 0.083 0.008 DBMET00153 0.052 0.014 DBMET00155 0.115 0.005 DBMET00808 | DBMET00808 | |
| 0.089 | 0.021 | 0.089 | Protease 3C (Human rhinovirus) inhibitor | 0.065 0.043 DBMET00154 0.084 0.024 DBMET00155 0.081 0.026 DBMET00808 | ||
| 0.088 | 0.021 | 0.109 | Aldose reductase inhibitor | 0.109 0.016 DBMET00154 0.051 0.038 DBMET00155 0.07 0.027 DBMET00668 0.07 0.027 DBMET00808 | DBMET00154 | |
| 0.096 | 0.029 | 0.139 | Prostaglandin-E synthase inhibitor | 0.139 0.014 DBMET00154 0.129 0.017 DBMET00808 | DBMET00154 | |
| 0.113 | 0.046 | 0.145 | Anabolic | 0.145 0.021 DBMET00154 0.095 0.069 DBMET00155 0.132 0.029 DBMET00668 0.105 0.055 DBMET00808 | DBMET00154 | |
| 0.081 | 0.014 | 0.081 | Thromboxane A2 antagonist | 0.059 0.029 DBMET00155 0.077 0.016 DBMET00668 0.071 0.02 DBMET00808 | ||
| 0.072 | 0.005 | 0.17 | Neutral endopeptidase inhibitor | 0.052 0.007 DBMET00155 0.17 0.004 DBMET00808 | DBMET00808 | |
| 0.074 | 0.008 | 0.119 | Fumarate hydratase inhibitor | 0.032 0.026 DBMET00153 0.119 0.004 DBMET00154 0.047 0.015 DBMET00155 0.055 0.012 DBMET00668 0.086 0.006 DBMET00808 | DBMET00154 | |
| 0.164 | 0.097 | 0.221 | P-glycoprotein inhibitor | 0.221 0.053 DBMET00153 | DBMET00153 | |
| 0.086 | 0.02 | 0.087 | Ornithine carbamoyltransferase inhibitor | 0.053 0.037 DBMET00154 0.087 0.019 DBMET00155 0.073 0.024 DBMET00668 0.076 0.023 DBMET00808 | DBMET00155 | |
| 0.09 | 0.024 | 0.118 | Carbamoyl phosphate synthetase inhibitor | 0.118 0.016 DBMET00154 0.095 0.022 DBMET00155 0.083 0.027 DBMET00668 0.08 0.029 DBMET00808 | DBMET00154 | |
| 0.079 | 0.014 | 0.089 | Angiotensin-converting enzyme inhibitor | 0.067 0.022 DBMET00155 0.05 0.047 DBMET00668 0.089 0.011 DBMET00808 | DBMET00808 | |
| 0.113 | 0.048 | 0.36 | UDP-glucose 4-epimerase inhibitor | 0.36 0.007 DBMET00153 0.101 0.06 DBMET00154 0.117 0.045 DBMET00155 0.103 0.058 DBMET00668 0.101 0.06 DBMET00808 | DBMET00153 | |
| 0.094 | 0.03 | 0.094 | CC chemokine 5 receptor agonist | 0.077 0.076 DBMET00808 | ||
| 0.077 | 0.013 | 0.077 | Oleamide hydrolase inhibitor | 0.045 0.032 DBMET00668 0.041 0.036 DBMET00808 | ||
| 0.081 | 0.018 | 0.109 | Endothelin-converting enzyme inhibitor | 0.054 0.028 DBMET00155 0.109 0.013 DBMET00808 | DBMET00808 | |
| 0.066 | 0.004 | 0.066 | Carboxypeptidase B inhibitor | 0.042 0.011 DBMET00154 0.048 0.007 DBMET00155 0.043 0.01 DBMET00668 0.065 0.004 DBMET00808 | ||
| 0.085 | 0.024 | 0.23 | Prostaglandin EP2 antagonist | 0.07 0.033 DBMET00668 0.23 0.005 DBMET00808 | DBMET00808 | |
| 0.124 | 0.063 | 0.251 | Beta amyloid protein antagonist | 0.251 0.008 DBMET00153 0.124 0.063 DBMET00668 | DBMET00153 | |
| 0.093 | 0.032 | 0.105 | T cell inhibitor | 0.105 0.021 DBMET00153 0.099 0.026 DBMET00154 0.08 0.067 DBMET00155 0.088 0.043 DBMET00668 0.081 0.061 DBMET00808 | DBMET00153 | |
| 0.098 | 0.038 | 0.098 | Granulocyte macrophage colony stimulating factor agonist | 0.09 0.051 DBMET00155 0.083 0.067 DBMET00668 0.091 0.049 DBMET00808 | ||
| 0.072 | 0.012 | 0.086 | Glucose-6-phosphate isomerase inhibitor | 0.086 0.007 DBMET00153 0.076 0.01 DBMET00154 0.078 0.009 DBMET00155 0.071 0.012 DBMET00668 0.077 0.009 DBMET00808 | DBMET00153 | |
| 0.078 | 0.017 | 0.089 | Elastase inhibitor | 0.05 0.041 DBMET00153 0.089 0.013 DBMET00155 0.048 0.045 DBMET00668 0.086 0.014 DBMET00808 | DBMET00155 | |
| 0.065 | 0.005 | 0.065 | Retinoid X receptor antagonist | 0.059 0.007 DBMET00154 0.058 0.007 DBMET00155 0.051 0.012 DBMET00668 0.061 0.006 DBMET00808 | ||
| 0.065 | 0.005 | 0.065 | Liver X receptor beta antagonist | 0.061 0.005 DBMET00154 0.05 0.008 DBMET00155 0.052 0.008 DBMET00668 0.055 0.007 DBMET00808 | ||
| 0.069 | 0.009 | 0.092 | Sphingosine 1-phosphate receptor 1 agonist | 0.041 0.031 DBMET00154 0.092 0.005 DBMET00155 0.067 0.009 DBMET00808 | DBMET00155 | |
| 0.066 | 0.007 | 0.117 | Liver X receptor beta agonist | 0.117 0.004 DBMET00154 0.039 0.016 DBMET00155 0.039 0.016 DBMET00668 0.043 0.014 DBMET00808 | DBMET00154 | |
| 0.184 | 0.126 | 0.192 | RNA-directed DNA polymerase inhibitor | 0.192 0.112 DBMET00154 0.166 0.161 DBMET00808 | DBMET00154 | |
| 0.069 | 0.012 | 0.098 | Sphingosine 1-phosphate receptor agonist | 0.098 0.006 DBMET00155 0.074 0.01 DBMET00808 | DBMET00155 | |
| 0.168 | 0.111 | 0.189 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.155 0.137 DBMET00154 0.189 0.082 DBMET00668 0.153 0.142 DBMET00808 | DBMET00668 | |
| 0.071 | 0.014 | 0.077 | Leukocyte elastase inhibitor | 0.077 0.013 DBMET00155 0.074 0.014 DBMET00808 | DBMET00155 | |
| 0.192 | 0.135 | 0.192 | Neuropeptide Y2 antagonist | |||
| 0.075 | 0.019 | 0.11 | Aminopeptidase N inhibitor | 0.051 0.03 DBMET00155 0.11 0.011 DBMET00808 | DBMET00808 | |
| 0.081 | 0.025 | 0.1 | Carbonic anhydrase stimulant | 0.06 0.04 DBMET00154 0.052 0.051 DBMET00155 0.1 0.018 DBMET00668 0.071 0.031 DBMET00808 | DBMET00668 | |
| 0.068 | 0.013 | 0.175 | Heparanase inhibitor | 0.175 0.002 DBMET00153 0.055 0.033 DBMET00155 0.058 0.026 DBMET00808 | DBMET00153 | |
| 0.107 | 0.052 | 0.107 | Creatine kinase inhibitor | 0.094 0.067 DBMET00154 0.103 0.056 DBMET00155 0.087 0.076 DBMET00668 0.094 0.067 DBMET00808 | ||
| 0.138 | 0.083 | 0.138 | Heat shock protein 70 antagonist | 0.129 0.126 DBMET00155 0.131 0.115 DBMET00808 | ||
| 0.079 | 0.025 | 0.079 | Ribonucleoside-diphosphate reductase inhibitor | 0.069 0.029 DBMET00155 0.07 0.029 DBMET00808 | ||
| 0.089 | 0.035 | 0.095 | CDC25A inhibitor | 0.077 0.047 DBMET00155 0.087 0.036 DBMET00668 0.095 0.03 DBMET00808 | DBMET00808 | |
| 0.067 | 0.014 | 0.067 | Fructose-1,6-bisphosphatase inhibitor | 0.042 0.036 DBMET00155 0.041 0.038 DBMET00808 | ||
| 0.062 | 0.009 | 0.067 | Membrane dipeptidase inhibitor | 0.055 0.012 DBMET00154 0.051 0.015 DBMET00155 0.067 0.008 DBMET00668 0.067 0.008 DBMET00808 | DBMET00808 | |
| 0.079 | 0.027 | 0.079 | Ribonucleotide reductase inhibitor | 0.07 0.031 DBMET00155 0.07 0.031 DBMET00808 | ||
| 0.056 | 0.004 | 0.056 | Retinoid X alpha receptor antagonist | 0.051 0.006 DBMET00154 0.051 0.006 DBMET00155 0.045 0.01 DBMET00668 0.053 0.005 DBMET00808 | ||
| 0.076 | 0.024 | 0.076 | Acyl-CoA dehydrogenase inhibitor | 0.066 0.029 DBMET00154 0.063 0.031 DBMET00155 0.068 0.028 DBMET00668 0.066 0.029 DBMET00808 | ||
| 0.07 | 0.018 | 0.07 | Dihydroorotate oxidase inhibitor | 0.054 0.041 DBMET00668 0.055 0.037 DBMET00808 | ||
| 0.066 | 0.015 | 0.075 | Secretase gamma inhibitor | 0.04 0.032 DBMET00154 0.057 0.021 DBMET00155 0.075 0.011 DBMET00668 0.052 0.024 DBMET00808 | DBMET00668 | |
| 0.064 | 0.013 | 0.082 | Urate transporter 1 inhibitor | 0.038 0.028 DBMET00668 0.082 0.007 DBMET00808 | DBMET00808 | |
| 0.227 | 0.177 | 0.227 | GABA C receptor rho-3 antagonist | |||
| 0.055 | 0.005 | 0.055 | Integrin alpha4beta7 antagonist | 0.022 0.014 DBMET00155 0.036 0.007 DBMET00808 | ||
| 0.13 | 0.081 | 0.444 | Neurotrophic factor | 0.122 0.091 DBMET00153 0.444 0.004 DBMET00668 0.118 0.099 DBMET00808 | DBMET00668 | |
| 0.065 | 0.017 | 0.065 | Carbonic anhydrase IV inhibitor | 0.043 0.03 DBMET00808 | ||
| 0.12 | 0.071 | 0.121 | Aldehyde dehydrogenase inhibitor | 0.121 0.07 DBMET00155 0.102 0.095 DBMET00808 | DBMET00155 | |
| 0.101 | 0.052 | 0.184 | Uric acid excretion stimulant | 0.131 0.032 DBMET00153 0.184 0.015 DBMET00808 | DBMET00808 | |
| 0.075 | 0.027 | 0.075 | Caspase 9 inhibitor | 0.057 0.054 DBMET00154 0.065 0.039 DBMET00155 0.064 0.04 DBMET00668 0.07 0.032 DBMET00808 | ||
| 0.072 | 0.024 | 0.072 | Acetyl-CoA transferase inhibitor | 0.048 0.045 DBMET00808 | ||
| 0.056 | 0.008 | 0.18 | Peroxisome proliferator-activated receptor delta antagonist | 0.18 0.004 DBMET00154 0.04 0.015 DBMET00155 0.171 0.004 DBMET00808 | DBMET00154 | |
| 0.052 | 0.005 | 0.052 | CXC chemokine 2 receptor antagonist | 0.032 0.012 DBMET00155 0.031 0.013 DBMET00808 | ||
| 0.102 | 0.055 | 0.118 | Glutamate (mGluR7) agonist | 0.098 0.064 DBMET00154 0.118 0.032 DBMET00668 0.093 0.075 DBMET00808 | DBMET00668 | |
| 0.051 | 0.005 | 0.068 | Integrin alpha4beta1 antagonist | 0.068 0.004 DBMET00808 | DBMET00808 | |
| 0.106 | 0.06 | 0.18 | Toll-Like receptor 4 antagonist | 0.18 0.01 DBMET00153 0.092 0.085 DBMET00155 0.103 0.064 DBMET00808 | DBMET00153 | |
| 0.067 | 0.021 | 0.067 | Sphingosine 1-phosphate receptor 1 antagonist | 0.052 0.047 DBMET00668 0.053 0.046 DBMET00808 | ||
| 0.049 | 0.004 | 0.049 | Nicotinic acid receptor 2 antagonist | 0.031 0.012 DBMET00154 0.029 0.014 DBMET00155 0.025 0.022 DBMET00668 0.038 0.006 DBMET00808 | ||
| 0.052 | 0.007 | 0.06 | ATP citrate lysase inhibitor | 0.06 0.005 DBMET00154 0.033 0.02 DBMET00155 0.037 0.016 DBMET00668 0.058 0.005 DBMET00808 | DBMET00154 | |
| 0.048 | 0.005 | 0.048 | Thyroid hormone agonist | 0.034 0.009 DBMET00154 0.033 0.01 DBMET00155 0.03 0.013 DBMET00668 0.036 0.008 DBMET00808 | ||
| 0.058 | 0.015 | 0.058 | Geranyltranstransferase inhibitor | 0.044 0.03 DBMET00154 0.043 0.031 DBMET00155 0.052 0.021 DBMET00808 | ||
| 0.09 | 0.047 | 0.09 | Inducible nitric-oxide synthase inhibitor | 0.078 0.067 DBMET00808 | ||
| 0.088 | 0.045 | 0.088 | Chymotrypsin inhibitor | |||
| 0.074 | 0.033 | 0.086 | NMDA receptor agonist | 0.061 0.045 DBMET00154 0.057 0.052 DBMET00155 0.068 0.038 DBMET00668 0.086 0.025 DBMET00808 | DBMET00808 | |
| 0.047 | 0.005 | 0.051 | Glutamate (mGluR3) agonist | 0.036 0.015 DBMET00154 0.043 0.008 DBMET00155 0.039 0.011 DBMET00668 0.051 0.005 DBMET00808 | DBMET00808 | |
| 0.073 | 0.032 | 0.082 | MDM2 inhibitor | 0.082 0.018 DBMET00154 0.067 0.046 DBMET00155 0.067 0.048 DBMET00808 | DBMET00154 | |
| 0.058 | 0.018 | 0.058 | Oxytocin agonist | 0.042 0.03 DBMET00155 0.047 0.026 DBMET00808 | ||
| 0.045 | 0.005 | 0.082 | Calcium-sensing receptor antagonist | 0.019 0.009 DBMET00155 0.082 0.004 DBMET00668 0.019 0.008 DBMET00808 | DBMET00668 | |
| 0.051 | 0.011 | 0.055 | Glutamate (mGluR8) agonist | 0.044 0.016 DBMET00154 0.039 0.024 DBMET00155 0.041 0.021 DBMET00668 0.055 0.009 DBMET00808 | DBMET00808 | |
| 0.092 | 0.052 | 0.113 | ATPase (Vacuolar H+) inhibitor | 0.113 0.025 DBMET00153 0.086 0.063 DBMET00155 0.102 0.037 DBMET00668 0.086 0.065 DBMET00808 | DBMET00153 | |
| 0.085 | 0.045 | 0.105 | Interferon agonist | 0.105 0.025 DBMET00153 0.085 0.045 DBMET00154 0.075 0.061 DBMET00155 0.075 0.06 DBMET00668 | DBMET00153 | |
| 0.054 | 0.014 | 0.128 | Sphingosine 1-phosphate receptor 3 agonist | 0.128 0.005 DBMET00155 | DBMET00155 | |
| 0.078 | 0.039 | 0.078 | Leukotriene synthesis inhibitor | 0.077 0.039 DBMET00808 | ||
| 0.062 | 0.023 | 0.062 | Bombesin 2 receptor antagonist | 0.055 0.028 DBMET00155 0.045 0.043 DBMET00668 0.056 0.027 DBMET00808 | ||
| 0.048 | 0.01 | 0.049 | Glutamate (mGluR8) antagonist | 0.037 0.022 DBMET00154 0.035 0.026 DBMET00155 0.034 0.028 DBMET00668 0.049 0.009 DBMET00808 | DBMET00808 | |
| 0.045 | 0.007 | 0.045 | 5-Alpha-reductase 2 inhibitor | 0.02 0.013 DBMET00668 0.019 0.014 DBMET00808 | ||
| 0.096 | 0.059 | 0.096 | Potassium channel (Ca-activated) activator | |||
| 0.041 | 0.005 | 0.145 | Free fatty acid receptor 1 agonist | 0.035 0.005 DBMET00154 0.031 0.006 DBMET00155 0.026 0.007 DBMET00668 0.145 0.004 DBMET00808 | DBMET00808 | |
| 0.088 | 0.052 | 0.088 | Factor XII inhibitor | |||
| 0.053 | 0.018 | 0.053 | HIV-1 protease inhibitor | 0.045 0.027 DBMET00154 0.045 0.028 DBMET00155 0.046 0.025 DBMET00808 | ||
| 0.039 | 0.003 | 0.039 | Retinoid X beta receptor antagonist | 0.035 0.004 DBMET00154 0.032 0.004 DBMET00155 0.028 0.005 DBMET00668 0.035 0.004 DBMET00808 | ||
| 0.04 | 0.005 | 0.042 | Prostaglandin H2 antagonist | 0.035 0.009 DBMET00154 0.034 0.009 DBMET00155 0.025 0.018 DBMET00668 0.042 0.005 DBMET00808 | DBMET00808 | |
| 0.05 | 0.015 | 0.05 | GABA uptake inhibitor | 0.037 0.03 DBMET00154 0.048 0.017 DBMET00155 0.044 0.021 DBMET00808 | ||
| 0.051 | 0.016 | 0.051 | Angiotensin AT1 receptor antagonist | 0.039 0.036 DBMET00154 0.044 0.027 DBMET00668 0.047 0.021 DBMET00808 | ||
| 0.07 | 0.035 | 0.088 | Interferon inducer | 0.088 0.018 DBMET00153 0.07 0.034 DBMET00154 0.062 0.049 DBMET00155 0.063 0.048 DBMET00668 | DBMET00153 | |
| 0.06 | 0.026 | 0.07 | Sphingosine 1-phosphate receptor 5 agonist | 0.051 0.044 DBMET00155 0.07 0.017 DBMET00808 | DBMET00808 | |
| 0.078 | 0.044 | 0.078 | Vanilloid 4 agonist | 0.07 0.065 DBMET00668 0.072 0.058 DBMET00808 | ||
| 0.045 | 0.011 | 0.045 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.037 0.014 DBMET00154 0.032 0.018 DBMET00808 | ||
| 0.053 | 0.02 | 0.086 | Liver X receptor agonist | 0.086 0.009 DBMET00154 0.039 0.037 DBMET00155 0.039 0.038 DBMET00668 0.042 0.032 DBMET00808 | DBMET00154 | |
| 0.086 | 0.053 | 0.086 | Glutathione S-transferase inhibitor | 0.075 0.071 DBMET00154 0.083 0.057 DBMET00155 0.081 0.059 DBMET00668 0.076 0.069 DBMET00808 | ||
| 0.048 | 0.015 | 0.048 | Nicotinic acid receptor 2 agonist | 0.032 0.03 DBMET00153 0.034 0.027 DBMET00808 | ||
| 0.048 | 0.015 | 0.048 | Aggrecanase 1 inhibitor | 0.039 0.028 DBMET00155 0.044 0.019 DBMET00808 | ||
| 0.043 | 0.011 | 0.064 | Cholesterol ester transfer protein antagonist | 0.036 0.016 DBMET00154 0.037 0.016 DBMET00155 0.064 0.004 DBMET00668 0.029 0.026 DBMET00808 | DBMET00668 | |
| 0.042 | 0.01 | 0.042 | Growth factor receptor-bound protein 2 antagonist | 0.035 0.025 DBMET00155 0.042 0.011 DBMET00808 | ||
| 0.097 | 0.065 | 0.097 | Nitric-oxide synthase inhibitor | |||
| 0.06 | 0.029 | 0.06 | Leukotriene C antagonist | 0.055 0.042 DBMET00154 0.055 0.044 DBMET00155 0.059 0.033 DBMET00808 | ||
| 0.057 | 0.026 | 0.057 | Lysophosphatidic acid 3 receptor antagonist | 0.047 0.041 DBMET00154 0.052 0.033 DBMET00155 0.057 0.026 DBMET00668 0.051 0.034 DBMET00808 | ||
| 0.048 | 0.017 | 0.06 | Kainate receptor 2 antagonist | 0.06 0.012 DBMET00808 | DBMET00808 | |
| 0.042 | 0.012 | 0.042 | Melatonin receptor 1A agonist | 0.037 0.017 DBMET00154 0.041 0.013 DBMET00155 0.037 0.017 DBMET00808 | ||
| 0.042 | 0.012 | 0.044 | HMG CoA reductase inhibitor | 0.034 0.025 DBMET00153 0.044 0.01 DBMET00154 0.042 0.013 DBMET00155 0.04 0.015 DBMET00668 0.041 0.013 DBMET00808 | DBMET00154 | |
| 0.075 | 0.046 | 0.079 | Histidine decarboxylase inhibitor | 0.079 0.043 DBMET00154 0.063 0.059 DBMET00808 | DBMET00154 | |
| 0.035 | 0.005 | 0.048 | Vanilloid 2 agonist | 0.048 0.003 DBMET00153 0.027 0.014 DBMET00154 0.027 0.014 DBMET00155 0.024 0.02 DBMET00668 0.032 0.007 DBMET00808 | DBMET00153 | |
| 0.059 | 0.029 | 0.061 | Leukotriene B4 antagonist | 0.059 0.029 DBMET00153 0.054 0.037 DBMET00154 0.055 0.035 DBMET00155 0.059 0.029 DBMET00668 0.061 0.026 DBMET00808 | DBMET00808 | |
| 0.038 | 0.009 | 0.038 | LFA antagonist | 0.03 0.015 DBMET00808 | ||
| 0.033 | 0.005 | 0.033 | ICAM 1 antagonist | 0.023 0.017 DBMET00155 0.026 0.01 DBMET00808 | ||
| 0.041 | 0.013 | 0.041 | Angiotensin II receptor antagonist | 0.034 0.023 DBMET00668 0.038 0.018 DBMET00808 | ||
| 0.04 | 0.012 | 0.063 | Cyclophilin A inhibitor | 0.063 0.005 DBMET00154 0.034 0.017 DBMET00668 | DBMET00154 | |
| 0.054 | 0.026 | 0.054 | Neurotensin receptor antagonist | 0.048 0.029 DBMET00808 | ||
| 0.032 | 0.004 | 0.032 | Nicotinic acid receptor 1 antagonist | 0.019 0.01 DBMET00155 0.028 0.005 DBMET00808 | ||
| 0.047 | 0.02 | 0.047 | Acetyl-CoA transferase 1 inhibitor | 0.037 0.034 DBMET00154 0.039 0.032 DBMET00808 | ||
| 0.064 | 0.037 | 0.065 | Collagenase 3 inhibitor | 0.065 0.036 DBMET00155 0.062 0.038 DBMET00808 | DBMET00155 | |
| 0.035 | 0.008 | 0.035 | Retinoid X gamma receptor antagonist | 0.033 0.009 DBMET00154 0.032 0.01 DBMET00155 0.031 0.012 DBMET00668 0.033 0.009 DBMET00808 | ||
| 0.065 | 0.038 | 0.069 | Prostaglandin F2 alpha antagonist | 0.059 0.049 DBMET00155 0.069 0.033 DBMET00668 0.057 0.051 DBMET00808 | DBMET00668 | |
| 0.031 | 0.004 | 0.031 | CXC chemokine 5 receptor antagonist | 0.019 0.01 DBMET00154 0.019 0.009 DBMET00155 0.022 0.006 DBMET00808 | ||
| 0.078 | 0.052 | 0.11 | Na+ K+ transporting ATPase inhibitor | 0.11 0.023 DBMET00153 0.077 0.054 DBMET00154 0.088 0.042 DBMET00155 0.09 0.041 DBMET00668 0.081 0.05 DBMET00808 | DBMET00153 | |
| 0.04 | 0.014 | 0.04 | Dipeptidyl peptidase II inhibitor | 0.037 0.017 DBMET00808 | ||
| 0.047 | 0.021 | 0.047 | Integrin alpha5beta1 antagonist | 0.038 0.033 DBMET00808 | ||
| 0.037 | 0.012 | 0.052 | Prostaglandin EP4 antagonist | 0.052 0.008 DBMET00808 | DBMET00808 | |
| 0.04 | 0.015 | 0.04 | Factor VII inhibitor | 0.027 0.023 DBMET00155 0.026 0.024 DBMET00668 0.031 0.019 DBMET00808 | ||
| 0.03 | 0.005 | 0.045 | G-protein-coupled receptor 120 agonist | 0.023 0.008 DBMET00155 0.045 0.004 DBMET00808 | DBMET00808 | |
| 0.095 | 0.07 | 0.095 | GABA C receptor rho-1 antagonist | |||
| 0.05 | 0.025 | 0.073 | NMDA receptor subunit 3B antagonist | 0.073 0.015 DBMET00668 0.054 0.022 DBMET00808 | DBMET00668 | |
| 0.08 | 0.056 | 0.107 | Glycine receptor antagonist | 0.107 0.026 DBMET00153 0.102 0.03 DBMET00154 | DBMET00153 | |
| 0.043 | 0.019 | 0.052 | Arginase inhibitor | 0.052 0.014 DBMET00153 0.043 0.02 DBMET00154 0.036 0.025 DBMET00155 0.037 0.024 DBMET00808 | DBMET00153 | |
| 0.032 | 0.008 | 0.035 | Prostaglandin F2 alpha agonist | 0.035 0.007 DBMET00154 0.032 0.008 DBMET00155 0.03 0.009 DBMET00668 0.028 0.01 DBMET00808 | DBMET00154 | |
| 0.027 | 0.003 | 0.027 | Carboxypeptidase B2 inhibitor | 0.01 0.009 DBMET00154 0.013 0.006 DBMET00155 0.01 0.008 DBMET00668 0.026 0.003 DBMET00808 | ||
| 0.038 | 0.015 | 0.097 | Prostaglandin EP3 antagonist | 0.097 0.006 DBMET00808 | DBMET00808 | |
| 0.077 | 0.054 | 0.077 | Estrogen receptor alpha antagonist | 0.074 0.059 DBMET00154 | ||
| 0.042 | 0.019 | 0.042 | p53 inhibitor | 0.042 0.019 DBMET00154 0.039 0.021 DBMET00155 | ||
| 0.037 | 0.015 | 0.042 | AMPA 3 receptor antagonist | 0.042 0.013 DBMET00808 | DBMET00808 | |
| 0.03 | 0.008 | 0.03 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.061 | 0.039 | 0.061 | Bombesin 1 receptor agonist | 0.055 0.047 DBMET00155 0.057 0.045 DBMET00808 | ||
| 0.03 | 0.009 | 0.03 | 5-Alpha-reductase 1 inhibitor | |||
| 0.037 | 0.015 | 0.103 | Prostaglandin agonist | 0.034 0.018 DBMET00154 0.029 0.024 DBMET00155 0.103 0.005 DBMET00668 | DBMET00668 | |
| 0.031 | 0.01 | 0.037 | Endothelin A receptor antagonist | 0.037 0.008 DBMET00155 0.03 0.01 DBMET00808 | DBMET00155 | |
| 0.056 | 0.035 | 0.056 | Matrix metalloproteinase 1 inhibitor | |||
| 0.029 | 0.009 | 0.029 | Integrin alphaVbeta3 antagonist | 0.02 0.018 DBMET00155 0.026 0.01 DBMET00808 | ||
| 0.031 | 0.011 | 0.031 | Prostaglandin D2 antagonist | 0.022 0.017 DBMET00154 0.025 0.014 DBMET00668 0.023 0.016 DBMET00808 | ||
| 0.04 | 0.02 | 0.043 | Calcitonin receptor agonist | 0.043 0.019 DBMET00155 0.036 0.022 DBMET00668 0.036 0.022 DBMET00808 | DBMET00155 | |
| 0.036 | 0.016 | 0.038 | Liver X receptor antagonist | 0.038 0.015 DBMET00154 0.028 0.026 DBMET00155 0.029 0.024 DBMET00668 0.032 0.021 DBMET00808 | DBMET00154 | |
| 0.029 | 0.01 | 0.029 | Glutamate (mGluR1) agonist | 0.027 0.013 DBMET00808 | ||
| 0.039 | 0.019 | 0.04 | AMPA receptor agonist | 0.035 0.024 DBMET00154 0.033 0.029 DBMET00155 0.04 0.017 DBMET00808 | DBMET00808 | |
| 0.051 | 0.031 | 0.051 | Collagenase inhibitor | 0.049 0.035 DBMET00808 | ||
| 0.06 | 0.041 | 0.066 | Cathepsin E inhibitor | 0.054 0.051 DBMET00154 0.066 0.033 DBMET00668 0.056 0.046 DBMET00808 | DBMET00668 | |
| 0.026 | 0.007 | 0.029 | Neuraminidase (Influenza B) inhibitor | 0.029 0.005 DBMET00154 0.023 0.011 DBMET00155 0.025 0.008 DBMET00668 0.023 0.01 DBMET00808 | DBMET00154 | |
| 0.041 | 0.023 | 0.042 | Glutamate (mGluR group II) antagonist | 0.042 0.022 DBMET00808 | DBMET00808 | |
| 0.026 | 0.009 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.023 0.015 DBMET00153 0.027 0.008 DBMET00155 0.022 0.016 DBMET00668 0.025 0.012 DBMET00808 | DBMET00155 | |
| 0.022 | 0.005 | 0.022 | Thyroid hormone alpha agonist | 0.021 0.006 DBMET00154 0.019 0.008 DBMET00155 0.016 0.013 DBMET00668 0.021 0.006 DBMET00808 | ||
| 0.054 | 0.036 | 0.087 | Alpha-mannosidase inhibitor | 0.087 0.009 DBMET00153 0.055 0.034 DBMET00154 0.058 0.03 DBMET00155 0.067 0.019 DBMET00668 0.049 0.046 DBMET00808 | DBMET00153 | |
| 0.024 | 0.006 | 0.031 | Estrogen-related receptor gamma agonist | 0.031 0.004 DBMET00155 0.021 0.009 DBMET00808 | DBMET00155 | |
| 0.031 | 0.015 | 0.047 | Leukotriene D4 antagonist | 0.03 0.015 DBMET00154 0.047 0.011 DBMET00668 0.034 0.014 DBMET00808 | DBMET00668 | |
| 0.019 | 0.003 | 0.019 | Immunosuppressant Cyclosporine-like | 0.017 0.004 DBMET00154 0.011 0.009 DBMET00155 0.017 0.004 DBMET00668 0.011 0.008 DBMET00808 | ||
| 0.032 | 0.016 | 0.038 | Liver X receptor alpha antagonist | 0.038 0.01 DBMET00154 0.027 0.025 DBMET00155 0.026 0.025 DBMET00668 0.029 0.021 DBMET00808 | DBMET00154 | |
| 0.024 | 0.008 | 0.027 | Aminopeptidase A inhibitor | 0.016 0.014 DBMET00155 0.027 0.007 DBMET00808 | DBMET00808 | |
| 0.027 | 0.012 | 0.027 | Vitronectin receptor antagonist | 0.022 0.014 DBMET00808 | ||
| 0.028 | 0.013 | 0.03 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.022 DBMET00154 0.03 0.011 DBMET00155 0.03 0.011 DBMET00668 0.026 0.016 DBMET00808 | DBMET00668 | |
| 0.041 | 0.027 | 0.041 | Dopamine D5 agonist | 0.036 0.034 DBMET00154 0.036 0.034 DBMET00808 | ||
| 0.036 | 0.023 | 0.036 | Tryptophan 5 hydroxylase inhibitor | 0.035 0.027 DBMET00668 | ||
| 0.048 | 0.035 | 0.048 | Metalloproteinase-3 inhibitor | 0.044 0.04 DBMET00155 0.046 0.038 DBMET00808 | ||
| 0.018 | 0.005 | 0.018 | Integrin beta2 antagonist | |||
| 0.019 | 0.006 | 0.019 | Angiotensin AT1B receptor antagonist | 0.016 0.008 DBMET00808 | ||
| 0.068 | 0.055 | 0.068 | Calcium channel L-type blocker | |||
| 0.058 | 0.046 | 0.058 | Purinergic P2X1 antagonist | 0.056 0.049 DBMET00154 | ||
| 0.023 | 0.011 | 0.034 | Endothelin B receptor antagonist | 0.034 0.008 DBMET00155 0.022 0.011 DBMET00808 | DBMET00155 | |
| 0.02 | 0.009 | 0.02 | Prostaglandin EP4 agonist | 0.013 0.011 DBMET00668 | ||
| 0.08 | 0.069 | 0.08 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.023 | 0.012 | 0.023 | Integrin beta5 antagonist | 0.019 0.017 DBMET00808 | ||
| 0.046 | 0.035 | 0.047 | GP IIb/IIIa receptor antagonist | 0.047 0.035 DBMET00808 | DBMET00808 | |
| 0.028 | 0.017 | 0.028 | Kynurenine 3 monooxygenase inhibitor | 0.027 0.018 DBMET00808 | ||
| 0.057 | 0.046 | 0.066 | Androgen agonist | 0.066 0.034 DBMET00154 | DBMET00154 | |
| 0.05 | 0.039 | 0.122 | Glucose-6-phosphate translocase inhibitor | 0.122 0.004 DBMET00153 0.059 0.025 DBMET00808 | DBMET00153 | |
| 0.058 | 0.048 | 0.078 | Transcription factor AP-1 inhibitor | 0.078 0.023 DBMET00153 | DBMET00153 | |
| 0.015 | 0.005 | 0.015 | Calcineurin inhibitor | 0.014 0.005 DBMET00668 | ||
| 0.117 | 0.107 | 0.128 | Mannose-6-phosphate isomerase inhibitor | 0.128 0.088 DBMET00153 | DBMET00153 | |
| 0.038 | 0.028 | 0.038 | Leukotriene C4 antagonist | 0.037 0.032 DBMET00808 | ||
| 0.062 | 0.052 | 0.07 | Calcium channel P-type blocker | 0.07 0.028 DBMET00154 | DBMET00154 | |
| 0.044 | 0.035 | 0.046 | Glycine transporter 2 inhibitor | 0.046 0.033 DBMET00154 | DBMET00154 | |
| 0.019 | 0.01 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.013 DBMET00155 0.019 0.011 DBMET00668 0.02 0.008 DBMET00808 | DBMET00808 | |
| 0.038 | 0.028 | 0.038 | Vanilloid 3 antagonist | |||
| 0.058 | 0.048 | 0.058 | Bcl-xL inhibitor | |||
| 0.016 | 0.006 | 0.016 | Integrin beta6 antagonist | 0.014 0.009 DBMET00155 0.015 0.008 DBMET00808 | ||
| 0.013 | 0.004 | 0.013 | Thyroid hormone beta agonist | 0.008 0.007 DBMET00808 | ||
| 0.019 | 0.009 | 0.026 | Telomerase stimulant | 0.026 0.004 DBMET00153 0.018 0.01 DBMET00668 0.017 0.012 DBMET00808 | DBMET00153 | |
| 0.018 | 0.009 | 0.018 | Thyroid hormone alpha antagonist | 0.015 0.012 DBMET00808 | ||
| 0.037 | 0.029 | 0.042 | Integrin alpha1beta1 antagonist | 0.042 0.017 DBMET00808 | DBMET00808 | |
| 0.022 | 0.014 | 0.032 | Lysophosphatidic acid 1 receptor antagonist | 0.032 0.005 DBMET00668 | DBMET00668 | |
| 0.013 | 0.005 | 0.037 | Thromboxane agonist | 0.01 0.009 DBMET00154 0.011 0.007 DBMET00155 0.037 0.003 DBMET00668 0.011 0.007 DBMET00808 | DBMET00668 | |
| 0.02 | 0.012 | 0.021 | Caspase 8 inhibitor | 0.021 0.012 DBMET00668 0.018 0.016 DBMET00808 | DBMET00668 | |
| 0.07 | 0.062 | 0.088 | Analgesic, opioid | 0.088 0.039 DBMET00808 | DBMET00808 | |
| 0.087 | 0.08 | 0.087 | Electrolyte absorption antagonist | |||
| 0.089 | 0.082 | 0.089 | Nav1.1 sodium channel blocker | |||
| 0.012 | 0.005 | 0.012 | Angiotensin AT2 receptor agonist | |||
| 0.046 | 0.04 | 0.046 | Dopamine beta hydroxylase inhibitor | |||
| 0.038 | 0.031 | 0.049 | Kainate receptor antagonist | 0.049 0.022 DBMET00808 | DBMET00808 | |
| 0.094 | 0.088 | 0.146 | Anesthetic local | 0.092 0.091 DBMET00155 0.146 0.051 DBMET00668 | DBMET00668 | |
| 0.064 | 0.058 | 0.079 | Exportin-1 inhibitor | 0.079 0.026 DBMET00668 | DBMET00668 | |
| 0.031 | 0.025 | 0.031 | Prostacyclin antagonist | |||
| 0.027 | 0.021 | 0.027 | Hedgehog signaling activator | |||
| 0.04 | 0.034 | 0.04 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.018 | 0.012 | 0.023 | Angiotensin-converting enzyme 2 inhibitor | 0.023 0.006 DBMET00808 | DBMET00808 | |
| 0.017 | 0.011 | 0.023 | Vitamin D receptor agonist | 0.018 0.009 DBMET00153 0.023 0.005 DBMET00154 0.02 0.007 DBMET00155 0.019 0.008 DBMET00668 0.015 0.014 DBMET00808 | DBMET00154 | |
| 0.054 | 0.048 | 0.054 | Botulinum neurotoxin type A inhibitor | |||
| 0.047 | 0.042 | 0.052 | Factor III inhibitor | 0.052 0.029 DBMET00153 0.048 0.041 DBMET00668 | DBMET00153 | |
| 0.022 | 0.017 | 0.051 | Prostaglandin E2 agonist | 0.051 0.005 DBMET00668 | DBMET00668 | |
| 0.013 | 0.008 | 0.146 | Calcium-dependent phospholipase A2 inhibitor | 0.146 0.003 DBMET00808 | DBMET00808 | |
| 0.036 | 0.032 | 0.036 | Cholecystokinin antagonist | |||
| 0.019 | 0.015 | 0.019 | Integrin beta7 antagonist | |||
| 0.086 | 0.082 | 0.086 | Carbonic anhydrase III inhibitor | |||
| 0.013 | 0.009 | 0.013 | Integrin alphaLbeta2 antagonist | |||
| 0.014 | 0.01 | 0.014 | Integrin alphaVbeta6 antagonist | |||
| 0.051 | 0.047 | 0.054 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.053 0.043 DBMET00153 0.054 0.041 DBMET00155 0.054 0.042 DBMET00668 | DBMET00668 | |
| 0.038 | 0.034 | 0.038 | Complement C3a chemotactic receptor antagonist | |||
| 0.008 | 0.005 | 0.008 | Free fatty acid receptor 2 antagonist | 0.008 0.006 DBMET00808 | ||
| 0.034 | 0.03 | 0.077 | NMDA receptor subunit 3A antagonist | 0.077 0.012 DBMET00668 0.035 0.03 DBMET00808 | DBMET00668 | |
| 0.021 | 0.018 | 0.025 | Vitamin D receptor antagonist | 0.024 0.011 DBMET00153 0.025 0.01 DBMET00154 0.022 0.015 DBMET00155 0.021 0.017 DBMET00668 | DBMET00154 | |
| 0.067 | 0.064 | 0.067 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.016 | 0.013 | 0.03 | Ileal bile acid transport inhibitor | 0.026 0.006 DBMET00153 0.03 0.005 DBMET00668 | DBMET00668 | |
| 0.007 | 0.004 | 0.007 | Integrin alpha5beta6 antagonist | 0.006 0.005 DBMET00154 0.006 0.005 DBMET00808 | ||
| 0.021 | 0.018 | 0.021 | Retinoid X gamma receptor agonist | |||
| 0.045 | 0.043 | 0.046 | HCV NS3/NS4A protease inhibitor | 0.046 0.04 DBMET00808 | DBMET00808 | |
| 0.134 | 0.132 | 0.134 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.013 | 0.011 | 0.048 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.048 0.004 DBMET00808 | DBMET00808 | |
| 0.018 | 0.016 | 0.018 | Integrin alphaVbeta1 antagonist | |||
| 0.022 | 0.02 | 0.022 | VLA-4 antagonist | |||
| 0.027 | 0.025 | 0.027 | Peptide deformylase inhibitor | 0.027 0.024 DBMET00808 | ||
| 0.035 | 0.034 | 0.037 | Erythropoietin receptor agonist | 0.037 0.031 DBMET00668 | DBMET00668 | |
| 0.041 | 0.04 | 0.042 | Antimetabolite | 0.042 0.038 DBMET00808 | DBMET00808 | |
| 0.077 | 0.077 | 0.082 | D-Ala-D-Ala ligase inhibitor | 0.082 0.063 DBMET00808 | DBMET00808 | |
| 0.027 | 0.027 | 0.048 | Prostaglandin D2 agonist | 0.031 0.022 DBMET00154 0.048 0.008 DBMET00668 | DBMET00668 | |
| 0.04 | 0.041 | 0.081 | Mannosidase inhibitor | 0.081 0.008 DBMET00153 0.041 0.039 DBMET00154 0.044 0.034 DBMET00155 0.055 0.021 DBMET00668 | DBMET00153 | |
| 0.017 | 0.019 | 0.024 | Kainate receptor 1 antagonist | 0.024 0.013 DBMET00808 | DBMET00808 | |
| 0.015 | 0.018 | 0.023 | Prostaglandin EP1 antagonist | 0.023 0.012 DBMET00808 | DBMET00808 | |
| 0.054 | 0.058 | 0.056 | Ryanodine receptor antagonist | 0.056 0.052 DBMET00154 | DBMET00154 | |
| 0.031 | 0.035 | 0.045 | G protein-coupled receptor agonist | 0.045 0.021 DBMET00808 | DBMET00808 | |
| 0.085 | 0.091 | 0.117 | Phosphodiesterase 6D inhibitor | 0.117 0.028 DBMET00153 | DBMET00153 | |
| 0.093 | 0.099 | 0.151 | Electron transport complex I inhibitor | 0.108 0.065 DBMET00154 0.151 0.02 DBMET00668 | DBMET00668 | |
| 0.051 | 0.059 | 0.054 | Pregnane X receptor antagonist | 0.054 0.049 DBMET00154 0.053 0.05 DBMET00668 | DBMET00154 | |
| 0.022 | 0.03 | 0.084 | Sodium/glucose cotransporter inhibitor | 0.084 0.003 DBMET00153 0.026 0.017 DBMET00154 | DBMET00153 | |
| 0.044 | 0.052 | 0.048 | CD45 antagonist | 0.048 0.04 DBMET00154 | DBMET00154 | |
| 0.052 | 0.06 | 0.069 | Lipocortins synthesis agonist | 0.069 0.022 DBMET00153 0.055 0.05 DBMET00154 0.056 0.046 DBMET00155 | DBMET00153 | |
| 0.128 | 0.138 | 0.148 | Psychostimulant | 0.145 0.121 DBMET00153 0.142 0.123 DBMET00154 0.14 0.126 DBMET00668 0.148 0.118 DBMET00808 | DBMET00808 | |
| 0.097 | 0.107 | 0.12 | M17 leucyl aminopeptidase inhibitor | 0.12 0.077 DBMET00808 | DBMET00808 | |
| 0.115 | 0.125 | 0.312 | Hemostatic | 0.312 0.014 DBMET00153 | DBMET00153 | |
| 0.053 | 0.064 | 0.065 | Sphingosine 1-phosphate receptor 4 agonist | 0.059 0.055 DBMET00155 0.065 0.049 DBMET00808 | DBMET00808 | |
| 0.021 | 0.034 | 0.091 | Sodium/glucose cotransporter 2 inhibitor | 0.091 0.003 DBMET00153 0.026 0.019 DBMET00154 | DBMET00153 | |
| 0.014 | 0.027 | 0.053 | Prostaglandin EP2 agonist | 0.021 0.017 DBMET00154 0.053 0.005 DBMET00668 | DBMET00668 | |
| 0.074 | 0.088 | 0.095 | Interleukin 5 antagonist | 0.095 0.047 DBMET00668 | DBMET00668 | |
| 0.059 | 0.073 | 0.087 | Epoxide hydrolase inhibitor | 0.087 0.035 DBMET00808 | DBMET00808 | |
| 0.039 | 0.055 | 0.065 | Parathyroid hormone antagonist | 0.065 0.009 DBMET00154 | DBMET00154 | |
| 0.009 | 0.027 | 0.032 | Prostacyclin agonist | 0.032 0.005 DBMET00668 | DBMET00668 | |
| 0.01 | 0.028 | 0.033 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.033 0.009 DBMET00668 | DBMET00668 | |
| 0.017 | 0.037 | 0.021 | Retinoic acid gamma receptor agonist | 0.021 0.018 DBMET00668 | DBMET00668 | |
| 0.053 | 0.073 | 0.086 | Trypsin inhibitor | 0.086 0.024 DBMET00808 | DBMET00808 | |
| 0.047 | 0.067 | 0.089 | NMDA 2C receptor antagonist | 0.089 0.02 DBMET00668 | DBMET00668 | |
| 0.025 | 0.046 | 0.043 | Farnesoid X receptor agonist | 0.043 0.02 DBMET00154 | DBMET00154 | |
| 0.038 | 0.062 | 0.059 | Aromatase inhibitor | 0.059 0.042 DBMET00154 | DBMET00154 | |
| 0.036 | 0.061 | 0.103 | Protein 50S ribosomal subunit inhibitor | 0.103 0.012 DBMET00153 | DBMET00153 | |
| 0.054 | 0.08 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.055 DBMET00668 | DBMET00668 | |
| 0.019 | 0.046 | 0.053 | Trypsin I inhibitor | 0.053 0.011 DBMET00808 | DBMET00808 | |
| 0.014 | 0.041 | 0.028 | Antibiotic Anthracycline-like | 0.028 0.004 DBMET00153 | DBMET00153 | |
| 0.052 | 0.08 | 0.222 | Antineoplastic antibiotic | 0.222 0.018 DBMET00153 0.112 0.041 DBMET00668 | DBMET00153 | |
| 0.024 | 0.053 | 0.043 | Purinergic P2X3 antagonist | 0.043 0.014 DBMET00155 | DBMET00155 | |
| 0.148 | 0.177 | 0.218 | DNA damaging | 0.218 0.101 DBMET00153 | DBMET00153 | |
| 0.076 | 0.106 | 0.096 | Xanthine oxidase inhibitor | 0.096 0.063 DBMET00153 | DBMET00153 | |
| 0.071 | 0.103 | 0.092 | Sphingomyelinase inhibitor | 0.092 0.069 DBMET00668 | DBMET00668 | |
| 0.038 | 0.074 | 0.055 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.055 0.035 DBMET00154 | DBMET00154 | |
| 0.02 | 0.059 | 0.035 | Toll-Like receptor 4 agonist | 0.035 0.007 DBMET00153 | DBMET00153 | |
| 0.086 | 0.127 | 0.102 | Acetylcholine release stimulant | 0.102 0.082 DBMET00153 | DBMET00153 | |
| 0.01 | 0.053 | 0.018 | Hexokinase stimulant | 0.018 0.016 DBMET00668 | DBMET00668 | |
| 0.087 | 0.131 | 0.103 | Estrogen antagonist | 0.103 0.092 DBMET00154 | DBMET00154 | |
| 0.044 | 0.089 | 0.091 | Adenine nucleotide translocase inhibitor | 0.091 0.005 DBMET00153 | DBMET00153 | |
| 0.018 | 0.068 | 0.034 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 DBMET00153 0.034 0.008 DBMET00668 | DBMET00668 | |
| 0.103 | 0.154 | 0.276 | NOS3 expression enhancer | 0.276 0.022 DBMET00153 | DBMET00153 | |
| 0.003 | 0.056 | 0.013 | Antibiotic Macrolide-like | 0.013 0.01 DBMET00153 | DBMET00153 | |
| 0.034 | 0.098 | 0.053 | Cytokine production stimulant | 0.053 0.023 DBMET00153 | DBMET00153 | |
| 0.032 | 0.097 | 0.354 | Selectin antagonist | 0.354 0.004 DBMET00153 | DBMET00153 | |
| 0.027 | 0.093 | 0.054 | Microtubule stabilization | 0.054 0.023 DBMET00153 | DBMET00153 | |
| 0.028 | 0.098 | 0.048 | Guanylate cyclase stimulant | 0.048 0.023 DBMET00808 | DBMET00808 | |
| 0.143 | 0.216 | 0.355 | Peptidyltransferase inhibitor | 0.355 0.011 DBMET00153 0.194 0.107 DBMET00155 0.3 0.024 DBMET00668 | DBMET00153 | |
| 0.024 | 0.1 | 0.047 | Carbonic anhydrase XIV inhibitor | 0.047 0.036 DBMET00153 | DBMET00153 | |
| 0.081 | 0.16 | 0.143 | Interleukin 4 antagonist | 0.143 0.056 DBMET00153 | DBMET00153 | |
| 0.009 | 0.089 | 0.02 | Corticosteroid-like | 0.02 0.017 DBMET00153 | DBMET00153 | |
| 0.046 | 0.127 | 0.063 | HIV-1 integrase inhibitor | 0.063 0.06 DBMET00154 | DBMET00154 | |
| 0.024 | 0.107 | 0.062 | Neuraminidase (Influenza A) inhibitor | 0.053 0.02 DBMET00153 0.051 0.023 DBMET00154 0.062 0.011 DBMET00668 | DBMET00668 | |
| 0.099 | 0.182 | 0.168 | DNA methyltransferase I inhibitor | 0.168 0.088 DBMET00153 | DBMET00153 | |
| 0.044 | 0.135 | 0.089 | Androgen antagonist | 0.089 0.056 DBMET00154 | DBMET00154 | |
| 0.073 | 0.166 | 0.329 | Lipid peroxidase inhibitor | 0.329 0.015 DBMET00153 0.142 0.074 DBMET00154 | DBMET00153 | |
| 0.098 | 0.198 | 0.239 | DNA methylase inhibitor | 0.239 0.055 DBMET00153 | DBMET00153 | |
| 0.022 | 0.14 | 0.08 | Neuraminidase inhibitor | 0.074 0.03 DBMET00153 0.08 0.026 DBMET00668 | DBMET00668 | |
| 0.04 | 0.159 | 0.071 | Somatostatin 1 agonist | 0.071 0.063 DBMET00668 | DBMET00668 | |
| 0.03 | 0.158 | 0.084 | Neuraminidase (influenza) inhibitor | 0.08 0.025 DBMET00153 0.084 0.023 DBMET00668 | DBMET00668 | |
| 0.045 | 0.185 | 0.232 | Bronchodilator | 0.232 0.014 DBMET00668 | DBMET00668 | |
| 0.052 | 0.213 | 0.132 | Transcription factor NF kappa B stimulant | 0.132 0.02 DBMET00153 | DBMET00153 | |
| 0.128 | 0.309 | 0.674 | Antiobesity | 0.674 0.013 DBMET00154 0.491 0.039 DBMET00668 0.21 0.197 DBMET00808 | DBMET00154 | |
| 0.132 | 0.314 | 0.567 | Toll-Like receptor 7 agonist | 0.32 0.098 DBMET00154 0.567 0.021 DBMET00668 0.222 0.176 DBMET00808 | DBMET00668 | |
| 0.131 | 0.313 | 0.563 | Toll-Like receptor agonist | 0.318 0.1 DBMET00154 0.563 0.022 DBMET00668 0.22 0.179 DBMET00808 | DBMET00668 | |
| 0.061 | 0.252 | 0.122 | Acetylcholine M1 receptor antagonist | 0.122 0.106 DBMET00668 | DBMET00668 | |
| 0.023 | 0.227 | 0.082 | Factor IXa inhibitor | 0.082 0.015 DBMET00153 0.069 0.021 DBMET00668 | DBMET00153 | |
| 0.039 | 0.245 | 0.08 | Aminoacyl-tRNA synthetase inhibitor | 0.08 0.077 DBMET00668 | DBMET00668 | |
| 0.007 | 0.219 | 0.042 | Glucocorticoid antagonist | 0.042 0.018 DBMET00154 | DBMET00154 | |
| 0.043 | 0.262 | 0.145 | Multidrug resistance-associated protein 1 inhibitor | 0.145 0.028 DBMET00153 | DBMET00153 | |
| 0.078 | 0.303 | 0.313 | Vasodilator | 0.313 0.044 DBMET00153 | DBMET00153 | |
| 0.079 | 0.309 | 0.122 | Papain-like protease (SARS coronavirus) inhibitor | 0.122 0.075 DBMET00154 | DBMET00154 | |
| 0.039 | 0.274 | 0.127 | AMP-activated protein kinase stimulant | 0.127 0.043 DBMET00153 0.103 0.067 DBMET00154 | DBMET00153 | |
| 0.073 | 0.31 | 0.429 | Tumour necrosis factor alpha release inhibitor | 0.429 0.022 DBMET00153 | DBMET00153 | |
| 0.014 | 0.264 | 0.127 | Mineralocorticoid receptor antagonist | 0.127 0.005 DBMET00154 | DBMET00154 | |
| 0.016 | 0.268 | 0.067 | Antibiotic Aminoglycoside-like | 0.067 0.007 DBMET00153 | DBMET00153 | |
| 0.059 | 0.374 | 0.128 | DNA repair enzyme inhibitor | 0.128 0.059 DBMET00153 | DBMET00153 | |
| 0.03 | 0.355 | 0.125 | Beta glucuronidase inhibitor | 0.125 0.042 DBMET00153 | DBMET00153 | |
| 0.018 | 0.356 | 0.07 | Topoisomerase II alpha inhibitor | 0.07 0.061 DBMET00153 | DBMET00153 | |
| 0.007 | 0.362 | 0.017 | Potassium channel (Inward rectifier) 11 blocker | 0.017 0.015 DBMET00154 | DBMET00154 | |
| 0.007 | 0.394 | 0.235 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.235 0.004 DBMET00154 | DBMET00154 | |
| 0.005 | 0.448 | 0.034 | Protein 30S ribosomal subunit inhibitor | 0.034 0.011 DBMET00153 | DBMET00153 | |
| 0.005 | 0.503 | 0.059 | Phosphodiesterase 2A inhibitor | 0.059 0.025 DBMET00154 | DBMET00154 | |
| 0.005 | 0.514 | 0.067 | Phosphodiesterase II inhibitor | 0.067 0.026 DBMET00154 | DBMET00154 | |
| 0.012 | 0.533 | 0.203 | Topoisomerase I inhibitor | 0.203 0.026 DBMET00153 | DBMET00153 | |
| 0.074 | 0.626 | 0.134 | CC chemokine 6 receptor antagonist | 0.134 0.057 DBMET00153 | DBMET00153 | |
| 0.03 | 0.591 | 0.096 | Toll-Like receptor 3 antagonist | 0.096 0.057 DBMET00668 | DBMET00668 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |